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ABSTRACT
Molecular Mechanism of Methyl Jasmonate Induced Apoptosis in Human Cancer
Cells
by
Venkat Laxmi Yeruva
Dr. Stephen W. Carper, Examination Committee Chair 
Professor of Biochemistry 
University of Nevada, Las Vegas
This study investigated the cytotoxic activity of four plant derived compounds including
perillic acid (PA), Perillyl alcohol (POH), cis-jasmone (CJ) and methyl jasmonate (MJ)
on a variety of human cancer cell lines: Breast (MDA-MB-435, MDA-MB-231, DC4,
DB46, T47D, SKBR3 and ZR75-1), Prostate (PC-3 and DU-145) and Lung (A549, H520
and H2170). It was demonstrated that these compounds induce cell cycle arrest and
apoptosis by themselves or in combination with other agents. Specifically, MJ decreases
membrane fluidity resulting in an activation of tumor necrosis factor receptor 1 (TNFRl)
which signals apoptosis via caspase 8 and 2. Combination studies demonstrated that
POH, MJ and cisplatin decreased viability, induced cell cycle arrest and activated
TNFRl. These results indicate that plant compounds show promise as an alternate
treatment option and the combination of these compounds with chemotherapeutic drugs
may decrease toxicity and improve efficacy over single agent therapy.
Ill
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CHAPTER 1 
INTRODUCTION
This dissertation has been organized as manuscripts and the following table outlines all 
my papers and their current status.
Manuscript Journal Status
Chapter 3
PA and MJ induced apoptosis
TIBETS In press
Chapter 4
Jasmonates induced apoptosis in 
NSCLC
Experimental Lung 
Research
2006 Nov-Dee; 
32(10);499-516.
Chapter 5
PA and POH induce apoptosis
Cancer Letters In the process of 
review
Chapter 6
Jasmonates induce apoptosis
Cancer
Chemotherapy and 
Pharmacology
Submitted
Chapter 7 
MJ acts via TNFRl
Cancer Research To be submitted
Chapter 8
Plant compounds sensitize 
breast cancer cells to cisplatin
Breast Cancer 
Research
To be submitted
1.1 Purpose of the study 
Cancer is a group of diseases characterized by uncontrolled growth. Cancer is 
caused by both external factors like radiation, chemicals, tobacco and infectious 
organisms and internal factors like mutations and hormones. These factors may act
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
together or in sequence to promote cancer initiation. Sometimes ten or more years pass 
between external factor exposure and cancer occurrence and detection. Cancer is the 
second leading cause of deaths in US. Lung, breast and prostate cancers account for 50% 
of cancer deaths in US [1].
The present treatment options for cancer are surgery, chemotherapy, radiation 
therapy and hormone therapy. One or a combination of these therapies have been used 
for cancer treatment but have been reported to cause severe side effects [1]. An alternate 
treatment option, such as plant compounds, can be efficient and advantageous due to 
lower toxicity to normal cells. In recent findings, plant compounds like monoterpenes 
and jamonates have been shown to inhibit cancer cell growth and possess anticancer 
properties [2-9]. The goal of this research is to study the cytotoxic effects o f 
monoterpenes and jasmonates on lung, prostate and breast cancer cells and elucidate their 
mechanism of apoptosis.
1.2 Significance of the study
Lung cancer is the leading cause of cancer deaths among men and women. An 
estimated 213,380 new cases and about 160,390 deaths are expected to occur in 2007 [1]. 
Lung cancer is classified as small cell (13%) or non small cell (87%) for treatment 
purposes. Cigarette smoking is the major risk factor for lung cancer in addition to 
exposure to radiation, air pollution and a history of tuberculosis. Treatment options are 
determined by the type and stage of cancer and include surgery, radiation therapy and 
chemotherapy. Because most of the patients present with an advanced stage of cancer 
treatment options have not been successful in controlling the disease [1].
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Prostate cancer is the second leading cause of cancer deaths and the most 
frequently diagnosed cancer among men in US. An estimated 218,890 new cases and 
27,050 deaths are expected to occur in 2007. The treatment options of prostate cancer are 
chemotherapy, radiation therapy, hormonal therapy or a combination therapy [1].
Breast cancer is the most frequently diagnosed cancer in women. About 40,000 
breast cancer deaths are expected and 200,000 new cases of breast cancer are predicted to 
occur in 2007. The major treatment options of breast cancer are radiation therapy, 
chemotherapy, hormone therapy, immunotherapy and sometimes two or more methods 
are used in combination [1].
To reduce the number of cancer deaths an alternative treatment method is needed 
to supplement the current treatment options. Plant compounds could be employed for 
chemotherapeutic purposes. By understanding the cellular mechanism of apoptosis, the 
pathways could be manipulated for therapeutic purposes. An earlier report demonstrated 
that MJ activated multiple signaling pathways in cancer cells [9]. Our study 
demonstrated that MJ activated a death receptor apoptotic pathway as well as a 
mitochondrial mediated pathway in lung, prostate and breast cancer cells. This study 
indicated that MJ induced multiple signaling pathways. Activation of multiple signaling 
pathways is a benefit for patients with mutations in apoptotic pathways. For example if 
the patient has mutation to any intrinsic apoptotic proteins (caspase-3, or caspase-9) 
jasmonates can still work through other pathways and induce apoptosis.
Ionizing radiation (IR) is one of the treatment options for cancer but it is not very 
effective and at high doses affects even normal cells. From an earlier report, cancer cells 
will be more sensitive to a combination treatment of plant compounds and low dose
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
radiation/chemotherapeutic drugs than by drugs themselves [59]. It will be of interest to 
study the sensitivity o f cancer cells to combination treatments (POH, MJ and cisplatin). 
Hence, complete mechanistic and combination studies are useful for better therapeutic 
option. Combination studies will also produce useful information in the design of 
experiments to test the toxicity of these treatments in animal models and for further 
clinical studies.
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CHAPTER 2
LITERATURE REVIEW
2.1 Cancer cell lines
Human non-small cell lung cancer (NSCLC) accounts for 50% of lung cancer 
related deaths. To represent NSCLC two well known NSCLC cell lines A549 and H520 
were studied. A549 is a human lung adenocarcinoma (glandular properties) cell line 
whereas H520 is a lung squamous cell carcinoma (no glandular properties) cell line. 
A549 has been reported to express wild type p53 (p53^) and H520 (p53 ) expresses a 
non-functional p53. Both cell lines possess the death receptor TNFRl [10,11].
Prostate cancer at initial stages is androgen dependent and has therapeutic options 
such as testosterone ablation and radical prostectomy. At advanced stages it becomes 
androgen independent which limits therapeutic options. To represent the advanced stage 
prostate cancer we have studied androgen insensitive cell lines PC-3 and DU-145. Both 
adenocarcinoma cell lines, express TNFRl and also high levels of Bela, but do not 
express p53 protein [12,13]
Based on National Cancer Institute current estimates, among the women that are 
bom today, 12.7 percent will be diagnosed with breast cancer at sometime in their lives. 
To represent breast cancer eight different breast cancer cell lines were used. They 
include: DC4, DB46, MDA-MB-231, MDA-MB-435, MCF-7, SK-BR-3, T47-D and ZR-
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
751. DC4 and DB46 cell lines were genetically engineered by Dr. S.W.Carper (UNLV) 
and the difference between them is heat shock protein 27 (hsp27) [14]. DC4 expresses 
normal levels of hsp27 while DB46 constitutively expresses high levels hsp27. MDA- 
MB-231, MDA-MB-435 cells are estrogen receptor negative (ER‘) and have mutant p53, 
express caspase-2, caspase-3, bax, bak and TNFRl [15, 16]. MDA-MB-231 cells are 
invasive whereas MDA-MB-435 cells are invasive and highly metastatic. MCF-7 cells 
are poorly invasive, express ER, p53, bax, bak, caspase-2, TNFRl and mutant caspse-3 
[17]. SK-BR-3 cells do not express estrogen receptor and p53 [15]. T-47-D cells express 
ER, p21, bax, bak, caspase-2, caspase-3, mutant p53 and does not express TNFRl [17]. 
ZR-751 cells are non-invasive, express ER, p21 and p53 [15]. Non tumorigenic breast 
epithelial cell line, MCFIOA and foreskin cell line, CDC-1070-SK were used as normal 
controls. All cell lines were purchased from ATCC (Manassas VA).
2.2 Monoterpenes and cancer
Monoterpenes are non-nutritive dietary compounds found in essential oils of fruits 
and vegetables. Limonene, a monocyclic monoterpene, administered in the diet at the 
mass percentages of 1-5% inhibited the 7, 12-dimethylbenz [o(|anthracene (DMBA) and 
N-methyl-N-nitrosourea (MNU)-induced mammary carcinogenesis in rats [18-21]. 
However, when limonene was removed from the diet the recurrence of tumor was 
observed hence limonene seems to act as cytostatic agent [22].
Perillyl alcohol (POH) is a naturally occurring monoterpene synthesized by the 
mevalonate pathway. It is a hydroxylated product formed by the condensation of two 
isoprene units. It is found in essential oils of mints, cherries, lavenders, lemongrass, sage.
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cranberries, perilla, wild bergamot, gingergrass, and savin, caraway and celery seeds [23, 
24]. POH has been shown to be more effective than its parent compound limonene in 
decreasing cancer cell growth and has shown chemo-preventive and therapeutic activity 
in DMBA-induced mammary cancer [2]. POH inhibited mouse lung, rat colon, rat liver 
and pancreatic tumor models that are induced by 4-(methyl-nitrosoamino)-l-(3-pyridyl)- 
1-butanone (NNK), azoxymethane (AOM) or diethyl-nitrosamine (DEN) [3-6, 25, 26]. 
In vitro studies have showed that POH inhibited the growth of human breast, colon, lung, 
murine glial, and hamster pancreatic ductal adenocarcinoma cells. [27-32].
Perillic acid (PA) has been found to be the major circulating metabolite of POH in 
animals and humans. [33-35]. Both POH and PA inhibit protein isoprenylation and 
induce cell cycle arrest at GO/Gl phase [36, 37]. In lung cancer cells POH has been 
shown to increase the expression of bax, bid and p21'^^, to induce apoptosis and cell 
cycle arrest and decrease the cycling D and cdk2 expression without changing p53 levels 
[29]. In H322 and H838 cells POH inhibited growth and activated caspase-3 [29]. Gene 
expression analysis showed that a large number of genes were up or down regulated in 
H322 and H838 cell lines, which suggests that POH mediates its effects through 
posttranslational modifications [29].
2.3 Jasmonates and cancer
Jasmonates are plant stress hormones synthesized in response to injury, insect 
attack and wounding [38]. Cis-jasmone and methyljasmonate belong to the jasmonte 
family of compounds. Jamonates are synthesized in the lipoxygenase pathway in plants 
[38] (Figure 5). It has been reported that jasmonates inhibit the growth of leukemia cells
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and lung cancer cells [7, 39]. Jasmonates have been shown to act directly on 
mitochondria and release cytochrome c which leads to apoptosis in leukemia cells [8]. In 
lung cancer cells, methyl jasmonate induced apoptosis via reactive oxygen species 
production, bax/bclx/s, and caspase-3 activation [39].
2.4 Apoptosis and apoptotic pathway
Cell death can be either a consequence of degenerative process (necrosis) or an 
active (apoptosis) process. Necrosis is morphologically different from apoptosis and its 
physiological consequences are also different from apoptosis. Necrotic cell death leads to 
inflammatory reactions, affects neighboring cells and it is difficult to control whereas 
apoptosis can be modulated to maintain cell viability [40,41].
Apoptosis is a programmed cell death that occurs to eliminate unwanted cells. It 
can occur by two different mechanisms, extrinsic or intrinsic [40, 41]. The extrinsic 
apoptotic mechanism involves death receptor ligands such as tumor necrosis factor alpha 
(TNF-a), TNF-related apoptosis inducing ligand (TRAIL) and FAS (CD95/APO-1) [46]. 
In cancer cells TNF-a plays an important role in cellular responses, including 
inflammation and apoptosis [42-45]. TNF-a binds to two membrane receptors, tumor 
necrosis factor receptor 1 (TNFRl) and tumor necrosis factor receptor 2 (TNFR2) [43]. 
TNFRl can be activated by both membrane bound and soluble TNF-a where as TNFR2 
activation occurs only by soluble TNF-a.[43, 45]. Following TNFRl and TNFR2 
activation, F ADD (Fas associated death domain) and TRADD (TNF receptor-associated 
death domain) recruitment leads to activation of caspase-8 and MAPK (p38 and ERKl/2) 
[45]. Several reports have demonstrated that caspase-8 and mitogen activated protein
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
kinase (MAPK) either directly activate caspase-3 via bid or activate the intrinsic 
apoptotic pathway [45-48].
Several reports have shown that in response to stimuli the MAPK pathway is 
activated which determines cell fate [48]. MAPK is part of an extrinsic apoptotic 
mechanism. MAPK proteins signal cells to either inhibit or induce apoptosis depending 
on the cell type, stimuli and time of activation. MAPKs (p38 and ERKl/2) regulate a 
number of downstream molecules, kinases, scaffold proteins and the balance between 
these molecules exerts cellular responses including cell proliferation, cell cycle arrest, 
migration, differentiation and apoptosis (48, 49). UV radiation has been shown to 
activate p38-MAPK, induce a G2/M block in the cell cycle and decrease Cdc2 activity in 
mammalian cultured cells (50). Cdc2 phosphorylates BAD and induces neuronal 
apoptosis (51, 52). A number of studies have reported that ERKl and ERK2 kinase 
activation leads to phoshorylation of other transcription factors including c-Myc and 
STAT proteins which results in cell death (52-55). Since it has been shown that the cell 
cycle plays a role in apoptosis it would be interesting to study the regulation of the 
MAPK pathway on the cell cycle and apoptosis.
Caspases are a family of cysteine proteases which are key mediators of apoptosis. 
They are synthesized as inactive proenzymes and activated by cleavage at a specific 
aspartate residue. To date, there are 14 caspases which are classified into three groups: 
apoptotic initiators (caspase-2, 8, 9 and 10), apoptotic executioners (caspase-3, 6 and 7) 
and cytokine precursors (caspase -1, 4, 5 13) [56]. Initiator caspases activate bid by 
direct cleavage or indirectly, which signals mitochondria. The intrinsic apoptotic 
mechanism involves mitochondrial membrane potential decrease and cytochrome c
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release into the cytosol. Cytochrome c forms an apoptosome complex with apaf-1 
(apoptotic protease activating factor-1) and procaspase-9, which activates apoptotic 
executioner’s caspase-3, caspase-6 and caspase-7 causing cell death [56-58].
2.5 Combination treatment and cancer
Exposing cancer patients to radiation is one of their treatment options. It is 
known that radiation therapy is limited due to severe toxicity at high doses and minimal 
efficacy at low doses. The search for compounds that sensitize cells to radiation will 
improve the efficacy of the therapy. Many research groups have reported that exposing 
cancer cells to radiation induced cell cycle arrest and apoptosis and activation of 
apoptotic proteins MAPK, caspases and PAR? in cancer cells [59]. Usually cancer cells 
are more sensitive to a combination treatment of radiation and chemotherapeutic drugs. 
Pretreatment o f cancer cells with resveratrol or genistein compounds have sensitized the 
cells to ionizing radiation [60]. Hence prior treatment of cancer cells with plant 
compounds sensitizes cells to ionizing radiation and would provide an alternate treatment 
option against cancer.
Combination treatments with low doses of two or three drugs could be an 
approach for cancer treatment because of severe toxicity and several side effects with 
regular chemotherapy. Several groups have reported that cancer cells are more sensitive 
to combination treatment than to any single drug. In breast cancer cells, Methyl-(3- 
dextrin sensitized cells to chemotherapeutic drugs by increasing the uptake of DNA 
damaging drugs at low dose and also showed decreased phosphorylation of Akt, 
activation of NF-kB and down regulation of Bcli (antiapoptotic protein) protein [61].
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Trastuzamab with clinically achievable concentrations of carboplatin, 4- 
hydroxycyclophosphamide, docetaxel and vinorelbine showed synergistic (cooperative 
effects) interactions in cancer cell death [62]. It has also been showed that grape seed 
extract of lOOpg/ml with doxorubicin (25-75nM) has synergistic effects in cancer cell 
growth inhibition and additive effects in cell death of MCF-7 cells [63]. Irofulven in 
combination with oxaliplatin led to synergistic activity in human colon, breast and 
ovarian cancer cells. Irofulven by itself blocks the cells at S phase whereas in 
combination with cisplatin or oxaliplatin blocks cells at the Gl/S phase while increasing 
the apoptotic population [64]. From all these studies it will be interesting to investigate 
the drug interactions with plant compounds in combination to improve the second line 
therapies for cancer.
2.6 Hypothesis
Plant compounds can induce apoptosis in human cancer cell lines via cell signaling 
pathways.
To test the hypothesis we will:
1. Examine sensitivity of POH, PA, CJ and MJ on breast (Chapter 7, 8 and 
Appendix), prostate (Chapter 6) and lung cancer cells (Chapter 3 ,4  and 5).
2. Evaluate cell cycle arrest and apoptosis in all three different types of cancer cells
(Chapter 3-8 and appendix)
3. Investigate cell signaling pathways (Chapter 3-8 and appendix)
4. Propose a molecular mechanism for MJ induced apoptosis.
11
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Figure 4a: Synthesis of 5-Phosphomevalonate from the condensation of two acetyl-CoA 
units via the mevalonate pathway (Adapted from McGarvey, D. J. and Croteau, R. 1995).
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Figure 4c: Cyclization of geranyl pyrophosphate to form naturally occuring 
monoterpenes limonene and POH (Adapted from McGarvey, D. J and Croteau, R. 1995).
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Figure 6: Proposed apoptotic pathway activated by jasmonates.
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CHAPTER 3
PLANT COMPOUNDS INDUCED CELL CYCLE ARREST AND APOPTOSIS IN
LUNG CANCER CELLS
3.1 Abstract
Human lung cancer is the most common cause of cancer deaths. It has been reported that 
naturally occurring plant compounds and their metabolites possess anticarcinogenic 
activities against different cancers. The effect of plant compounds, methyl jasmonate 
(MJ) and perillic acid (PA) on the proliferation of human lung squamous cell carcinoma 
cell lines (NCI-H520 and NCI-H2170) and human lung adenocarcinoma cell line (A549) 
were studied using proliferation, cytotoxicity assays, flow cytometry, enzyme linked 
immunosorbent assay and western analyses techniques. MJ and PA induced dose 
dependent decrease in the proliferation of the lung carcinoma cell lines in vitro. Flow 
cytometric analyses indicated S phase and G2/M arrest as well as apoptosis in all cell 
lines. PA and MJ significantly (p<0.01) elevated the level of the p53 protein in A549 and 
NCI-H2170 but not in the NCI-H520, a low p53 expressing cell line. In conclusion the 
mechanism of apoptosis induction does not involve p53.
3.2 Introduction
Lung cancer is the most common cause of cancer deaths among men and women 
in the US [1]. The etiology of lung cancer involves multiple genetic abnormalities
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leading to malignant transformation of the bronchial epithelial cells, followed by invasion 
and metastasis [2]. One of the most common changes in lung cancer is mutation of the 
p53 tumor suppressor gene [3]. The frequency of p53 mutation is highest in small cell 
and squamous cell carcinoma [3]. Clinical studies suggest that lung cancers with p53 
mutations are more resistant to chemotherapy and radiation [4]. An understanding of the 
role of p53 in human lung cancer will lead to a novel target for the treatment of the 
disease.
Naturally occurring plant compounds such as the monoterpenes and jasmonates 
represent a new class of anti-cancer agents with chemopreventive and chemotherapeutic 
potentials against a variety of cancers [5, 6]. Perillyl alcohol (POH) is a naturally 
occurring monoterpene, metabolized to perillic acid (PA) and dihydroperillic acid 
(DHPA) in experimental animals [7]. PA has been reported to inhibit the growth of 
human cancer cells in vitro [8, 9]. Although the mechanism of anti-tumor action of the 
monoterpenes is not yet known, potential drug related activities have been reported [10- 
12]. The jasmonates are a group of plant stress hormones involved in plant intracellular 
signaling and defense in response to injury [13, 14]. Methyl jasmonate (MJ), the most 
effective compound in the class has been reported to induce cell death in lymphoblastic 
leukemia (MOLT-4) and lung cancer cells cultured in vitro without affecting normal 
human blood lymphocytes or erythrocytes [15].
p53 is a tumor suppressor protein that induces either cell cycle arrest or apoptosis, 
with the latter activity being important for tumor suppression [16, 17]. The p53 protein is 
normally short lived and is maintained at low levels in unstressed mammalian cells, 
accumulates in the nucleus and is activated as a transcription factor in response to
19
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genotoxic and non-genotoxic stresses [18, 19]. p53 induces the expression of
downstream proteins, p21 and bax, that are essential for the inhibition of cell cycle 
progression and/or the induction of apoptosis [20]. p21 inhibits cyclin dependent kinases 
(cdk2/cdk4) and eventually leads to cell cycle arrest at Gq/Gi and Gz/M phases [21]. 
Direct activation of bax by p53 permeabilizes the mitochondrial membrane to release 
cytochrome c which leads to caspase-3 activation and apoptosis [23].
Earlier report on POH and PA showed proliferation inhibition of human lung 
squamous cell carcinoma cell lines [NCI-H520 and NCI-H2170] in a dose and time 
dependent manner [8, 9]. In this study the effects of PA and the naturally occurring 
compound MJ on human lung squamous cell carcinoma cell lines (NCI-H520 and NCI- 
H2170) and the lung adenocarcinoma cell line (A549) were investigated. It was 
determined that PA and MJ inhibited the growth of lung cancer cells, induced apoptosis 
and increased the expression of p53. In conclusion PA and MJ induced apoptosis does 
not involve the p53 protein.
3.3 Materials and methods 
Chemicals and reagents 
Perillic acid was purchased from Aldrich Chemical Company (Milwaukee, WI). 
Methyl jasmonate, protease inhibitors, propidium iodide (PI) and ribonuclease (RNase) 
were obtained from Sigma Chemical Company (St. Louis, MO). Cell culture media 
(RPMI, and Ham’s F-12K) were obtained from ATCC (Manassas, VA). Phosphate 
buffered saline (PBS, lacking Ca^^ and Mg^^) was obtained from Invitrogen Corporation 
(Grand Island, NY). Fetal bovine serum (FBS), penicillin (1000 units/ml) and
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streptomycin (1000 pg/ml) (P/S) were obtained from Hyclone Laboratories (Logan, UT). 
p53 ELISA kit, protein extraction buffer and alamarBlue were purchased from Biosource 
Int., Inc. (Camarillo, CA). Annexin V-FITC kit was obtained from BD Biosciences 
Pharmingen (San Jose, CA). Sodium dodecylsulfate, bisacrylamide, N,N,N,N*- tetra- 
methylehtylenediamine (TEMED) and ammonium persulfate were obtained from Bio- 
Rad Laboratories (Hercules, CA). p53 protein standard, antibody to p53 and enzyme 
conjugated HRP secondary antibody were obtained from Santa Cruz Biotechnology, Inc. 
(Santa Cruz , CA). ECL+ western blotting detection system was from Amersham 
Biosciences (Piscataway, NJ).
Cells and cell culture 
Human squamous cell carcinoma of the lung (NCI-H520, NCI-H2170), and 
human lung adenocarcinoma cell line (A549) were obtained from ATCC (Manassas, 
VA). The cells were cultured in appropriate medium supplemented with 10% FBS and 
1% Penicillin and Streptomycin. Generally, seeded cells were allowed to grow till 80% 
confluent, dislodged by trypsinization, counted and the required number of cells was 
taken for each experiment. For treatment, PA or MJ was dissolved in DMSG to give 
l.OM stock solutions. Cells were treated by replacing the culture medium with the 
treatment medium containing the desired concentrations of each agent and incubated at 
37°C in humidified, 5% CO2 atmosphere. Cells in control wells received medium with 
DMSO (<0.3% v/v). At termination, effects of the treatment agents were determined as 
described below.
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Proliferation and cytotoxicity assays
The cytotoxic effects of PA and MJ on lung cancer cells were studied using the
alamarBlue assay [24]. AlamarBlue is an oxidation-reduction dye that changes color in
growth medium in response to cell growth. In the reduced (fluorescent) state the dye
appears pink while in the oxidized (non-fluorescent) state it retains the blue color. Cells
(5 X 10 )̂ were seeded in 96-well plates and allowed to adhere overnight. The culture
medium was then replaced with 100 pi of treatment or control medium and incubated at
37°C in humidified 5% COz atmosphere for desired time period. At termination, the
treatment medium was aspirated off and replaced with 100 pi of fresh medium and 10 pi
of the alamarBlue dye. The mixture was incubated at 37°C in humidified, 5% COz for 4
hr and the fluorescence measured at 530nm excitation and 590nm emission wavelengths
using GENios fluorescence plate reader (PHENIX Research Products, Hayward, CA).
Cell viability was determined as follows:
Viability (%) = Fluorescence at 590nm of treated group x 100 
Fluorescence at 590nm of untreated group
Colony formation assay 
The long-term effects of agents on cancer cells were determined using the colony 
formation assay. Cells were exposed to the agents for 6, 9 or 24 hr, washed with PBS 
and placed in culture medium. The cells were then cultured for 14 days prior to staining 
with crystal violet and the colonies were counted.
DNA content analyses 
DNA content analysis was performed to determine the effects of PA and MJ on 
cell cycle progression and apoptosis induction. Cells (0.5-1x10®) were plated in 100mm
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plates and exposed to 0, ImM PA and 2mM MJ for 72 hr. At termination cells were 
harvested, counted, washed with IX PBS, fixed in 100% ethanol and stored at 4°C. For 
DNA analysis the cells were stained with DNA staining solution (lOOpg/ml PI, 0.1% of 
Triton X-100, and 1 mg/ml RNase A (DNase-free) in PBS lacking Ca^^ and Mĝ "̂ , 1:1:1 
by volume) and analyzed using FACSCalibur flow cytometer (Becton Dickinson, San 
Jose, CA). Twenty thousand events were acquired and the proportion of hypodiploid 
events and cells in G q/ G i , S and G%/M phases were determined using the DNA analysis 
software ModfitLT 3.0 (Verity Software, Topsham, Maine).
Annexin V-FITC assav 
The transversion of phosphatidylserine (PS) fi-om the inner to the outer leaflet of 
the plasma membrane is an initial event in cells undergoing apoptosis and is assessed by 
dual PI and annexin V-FITC staining [24]. To confirm the induction of apoptosis, control 
and treated cells were stained with annexin V-FITC and incubated in the dark for 15 
minutes according to the manufacturer’s instructions (BD Pharmingen, San Jose, CA). 
Acquisition to discriminate between apoptotic and necrotic or dead cells was carried out 
by staining the cells-conjugate mixture with 10 pL PI (500pg/mL) solution (BD 
Pharmingen, San Jose, CA). All color assessments were logarithmically amplified and 
10,000 events were acquired on a FACSCalibur flow cytometer (Becton Dickinson, San 
Jose, CA) and analyzed using CellQuest software program (Becton Dickinson, San Jose, 
CA). Numeric quantitation of these events was accomplished by population gating.
Expression of p53
The expression levels of p53 in lung cancer cells were determined using both the 
enzyme-linked immunosorbent assay (NCI-H520 and NCI-H2170) and western blotting
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techniques (NCI-H520, NCI-H2170 and A549). Control or treated cells (0.5-1x10®) were 
harvested and cell lysis was carried out using cell extraction buffer (lOmM Tris, pH 7.4, 
lOOmM NaCl, ImM EDTA, ImM EGTA, ImM NaF, 20mM Na4P207, 2mM Na3V04, 
1% Triton X-100, 10% glycerol, 0.1% SDS, 0.5% deoxycholate) according to the 
manufacturer’s instructions (Biosource Intl. Inc., Camarillo, CA). For Ix 10® cells lOOpl 
of extraction buffer containing protease inhibitor and PMSF was added and incubated on 
ice for 30 min. The cell lysate was centrifuged at 10000 rpm for 10 min at 4°C and the 
supernatant was collected, aliquoted and stored at -20°C. Total protein was determined 
using the BCA protein assay kit (Pierce, Rockford, IE).
Quantitative determination of p53 protein was carried out by an ELISA method 
according to the manufacturer’s instructions (Biosource Intl. Inc., Camarillo, CA). 
Aliquots (lOOpl) of standard and cell lysates (1:10 dilution) were transferred into a 96- 
well plate and incubated for 2 hr at room temperature. The wells were washed with wash 
buffer and lOOpl of detection antibody was added and incubated for 1 hr. The mixture 
was again washed with the wash buffer and lOOpl of HRP anti-rabbit antibody was added 
and incubated for 30 min at room temperature. After washing with the wash buffer, 
stabilized chromogen was added and the mixture was incubated for 30 min at room 
temperature. Finally, lOOpl of stop solution was added and the absorbance was read at 
450 nm.
Western blot analysis was performed to determine the expression levels of p53 
protein. Equal amounts of protein (lysates) were loaded onto SDS polyacrylamide gel 
and electrophoresis was carried. The proteins were transferred to PVDF membrane and
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probed with 1:1000 dilutions of primary and secondary antibodies. The membrane was 
developed with ECL+ and proteins were detected using the TYPHOON^'^.
3.4 Statistical analysis 
Results were expressed as Mean ± SEM of replicate analyses accompanied by the 
number of independent experiments. Statistical analyses were performed using t-test and 
ANOVA. Differences at p<0.05 or better were considered statistically significant.
3.5 Results
Perillic acid and methvl jasmonate inhibited the proliferation of lung cancer cells 
Exposure to PA or MJ inhibited the proliferation of lung cancer cells in dose 
dependent manner (Figure 1). The concentration of PA that inhibited cell proliferation by 
50% (IC50) at 72 hr was calculated (Figure 1) to be 2.8mM (A549), 3mM (NCI-H520), 
and 2.8mM (NCI-H2170). The 72 hr MJ IC50 values for the respective cell lines were 
1.8mM (A549), 2.2mM (NCI-H520), and 1.3mM (NCI-H2170). A549 and NCI-H2170 
cells were more sensitive than NCI-H520 to MJ than to PA. The long-term effects of PA 
or MJ in lung cancer cells were determined by colony formation assay (CFA) (Figure 2). 
There was a significant decrease in survival by PA or MJ at 24 hr in A549, NCI-H520 
and NCI-H2170 cells. Treatment with PA for 24 hr inhibited proliferation of A549 by 
14%, NCI-H520 by 24% and NCI-H2170 by 24%. In A549, NCI-H520 and NCI-H2170, 
2mM MJ showed 55%, 30% and 4% survival respectively (Figure 2).
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PA and MJ induced cell cycle arrest and apoptosis in cancer cells 
The effects of PA and MJ on cell cycle distribution and sub-diploid DNA content 
of cancer cells were studied to determine the observed inhibition of proliferation was a 
result of cell death via apoptosis. PA and MJ induced an S phase block in A549 and 
NCI-H520 as well as Gz/M block in NCI-H2170 cells (Table 1). The cell cycle block in 
each cell line was accompanied by an increase in the proportion of hypodiploidy except 
inNCI-H520 cells (Table 1).
To confirm the observed cell death was a result of apoptosis, the dual annexin V- 
FITC and PI staining technique was used as explained in methods. Cells in lower left 
(LL) quadrant were considered as live cells. Apoptotic (Table 2) cells were calculated as 
the sum of cells in lower right (LR) and upper right (UR) quadrants. Cells in upper left 
(UL) were considered as necrotic cells. Exposure to ImM PA for 12 hr, the fold increases 
in apoptotic cells were 2.26 (A549), 1.03 (NCI-520) and 1.01 (NCI-H2170) respectively 
(Table 2). Exposure to 2mM MJ produced 9.62 (A549), 1.47 (NCI-H520) and 1.37 
(NCI-H2170) fold increases in apoptotic cells compared to the control (1) (Table 2). The 
proportion of necrotic cells was low in each case. The observed proliferation inhibition 
was a result of cell cycle arrest and apoptosis induction.
Expression of p53 in A549. NCI-H520 and NCI-H2170 cells 
Since the tumor suppressor protein p53 is involved in the regulation of cell cycle 
progression, the expression levels of the p53 protein following treatment with PA or MJ 
were measured. In NCI-H520 cells PA or MJ did not affect the expression levels of p53 
(Table 3; Figure 3) compared to the control. In NCI-H2170 cells PA or MJ treatment 
resulted in 2.4 fold increase in the level of p53 compared to the control (1) ( Table 3).
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Western blot analyses revealed that PA or MJ increased the levels of p53 in both A549 
andNCI-H2170 cells (Figure 3).
3.6 Discussion and conclusion
Proliferation, cytotoxicity, flow cytometric, ELISA and western blot techniques 
were used to evaluate the potential effects of PA and MJ on human lung cancer cell lines 
in vitro. PA and MJ inhibited the proliferation of human lung cancer cells in a dose 
dependent manner (Figure 1). NCI-H2170 and A549 cell lines were more sensitive to MJ 
(ICso: 1.3 and 1.8 mM) than NCI-H520 (IC50: 2.2 mM) cell line (Figure 1). The 
sensitivity of the cell lines to PA appeared to be identical with IC50 values between 2.8 
and 3 mM (Figure 1). DNA content analyses using flow cytometric method indicated 
that exposure of the cells to PA or MJ resulted in cell cycle arrest and apoptosis (Table 
! )•
Since the early events of apoptosis involve the transversion of phosphatidylserine 
from the inner to the outer leaflet of the plasma membrane. The effects of PA or MJ 
after 12 hr treatment were studied, time where early apoptotic events would have 
occurred. It was found that ImM PA produced 126% increase (A549) and very little 
increases (NCI-H520 and NCI-H2170) in the sum of apoptotic cells over the control 
respectively (Table 2) while MJ produced 863%, 47%, 37% increases in apoptotic 
populations respectively in the same cell lines after 12 hr exposure. These results 
confirm that the observed decrease in viability (Figure 1) in the treated cells was a result 
of cell cycle arrest accompanied by apoptosis induction (Tables 1 and 2).
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Cells were exposed to the agents for a short period (6, 9, 24 hr) and long-term 
proliferation effects were determined. It was found that exposure to PA for 24 hr 
inhibited proliferation of A549, NCI-H520 and NCI-H2170 cells lines by 14%, 24% and 
24% respectively (Figure 2). Similar treatment with MJ inhibited the long-term 
proliferation by 45%, 70% and 96% respectively (Figure 2). This study showed that 
long-term proliferation inhibition was a result of the late induction of apoptosis in the 
cells treated with these agents.
Since the p53 tumor suppressor protein is involved in the regulation of cell cycle 
and induction of apoptosis levels of p53 were measured following treatment with PA or 
MJ. In NCI-H2170 cells PA or MJ increased p53 expression. Similar treatment did not 
affect the level of p53 in NCI-H520 cells (Table 3). Western blot analyses (Figure 3) 
confirmed this trend. Exposure of A549 cells also showed a similar trend compared to 
NCI-H2170 cells. These results indicate that cancer cells with wild type p53 (NCI- 
112170 and A549) respond to PA and MJ by increasing the expression level of p53 
protein whereas those with the mutant p53 (NCI-H520) did not alter expression level 
(Table 3; Figure 3). However, since all the cell lines underwent apoptosis (Tables 1 and 
2) following exposure to PA or MJ, we propose that the mechanism of apoptosis 
induction in lung cancer cells does not involve p53
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3.9 Figure legends
Figure 1: Cytotoxic effects of PA or MJ in lung cancer cells were measured by 
mitochondrial dehydrogenase assay as explained in methods. Panel A: A549 cells were 
exposed to varying concentrations of PA or MJ for 72 hr. Panel B: NCI-H520 cells were 
exposed to different concentrations of PA or MJ for 72 hr. Panel C: NCI-H2170 cells 
were exposed to different concentrations of PA or MJ for 72 hr. Cell viability was 
calculated as a percentage of untreated control cells (100%). PA showed significant 
growth inhibition at 2mM and higher concentrations in A549 and NCI-H520 (p<0.01). In 
NCI-H2170 cells significant growth inhibition was observed with PA from ImM -3mM 
(p<0.01). In A549 and NCI-H2170 cells MJ showed significant growth inhibition at all 
concentrations studied (p<0.01- p<0.001). MJ showed significant growth inhibition of 
NCI-H520 cells at 2 mM -3 mM. Values are Mean ± SD (n=6); results are representative 
of three different experiments.
Figure 2: PA and MJ caused long-term proliferation inhibition of cells in culture. Human 
lung cancer (A549; NCI-H520; NCI-H2170) cells were exposed to ImM PA or 2mM MJ 
for 6hr, 9hr and 24hr and the effects determined by colony formation assay as described 
in the Methods section. Colonies (>50 cells/colony) were counted and the cell viability 
was calculated as percentage of control groups (100%). PA and MJ showed significant 
decrease in survival at 24 hr in all three cell lines (p<0.01). Values are Mean ± SD (n=4, 
results are representative of two independent experiments.
Figure 3: p53 expression profile in A549, NCI-H520 and NCI-H2170 cells following 72 
hr exposure to the agents. Equal amounts (30pg) of protein were loaded, SDS-PAGE 
was carried out and the proteins transferred to PVDF membrane. The membrane was
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probed with 1:1000 dilutions of p53 primary and secondary antibodies and developed 
with ECL+. The proteins were detected using the TYPHOON™. Increased p53 levels 
were observed in A549 and NCI-H2170 cells but not in NCI-H520 (expresses low levels 
of p53).
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Table 1 : Effects of PA and MJ on cell cycle distribution and hypodiploidy in lung cancer 
cells exposed for 72 hr
Cell line Treatment
Cell cycle phases
Go/Gi S Gz/M Apoptosis
A549 Control 
ImM PA 
2mMMJ
59.4±4.8
62.1±2.8
68.2±2.5
10.0± 1.2
37.9±0.0
28.7±0.5
30.7±4.9
O.OiO.O
1.9±0.46
5.0±1.7
18.1±2.8
28.2±1.4
NCI-H520 Control 
ImM PA 
2mM MJ
49.9±2.9
42.3±2.1
26.7±2.1
8.6± 1.0
46.5±5.7
62.3±3.6
41.4±3.4
11.2±3.5
11.0±3.4
O.liO.l
3.4±0.2
0.7±0.4
NCI-H2170 Control 
ImM PA 
2mM MJ
51.9±3.5
48.0±3.9
58.3±1.5
45.9±5.3
32.7±2.8
0±0.0
5.4±3.0
19.3±2.8
41.7±1.5
3.0±1.0
14.8±1.2
10.9±1.4
Cancer cells (1 x 10®) were plated in lOOnun tissue culture plates and treated with PA or 
MJ for 72 hr and analyzed on a FACSCalibur flow cytometer as described in the method. 
Values are Mean±SEM of triplicate analyses. p<0.03 was considered to be significant by 
one way ANOVA analysis.
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Table 2: PA and MJ induced apoptosis in lung cancer cells.
Treatment 
12 hr
A549
Live Apoptotic Necrotic
Control 91.2±0.0 6.5±0.0 2.2±0.0
ImM PA 82.8±2.5 14.7±3.7 2.5±1.1
2 mM MJ 34.8±0.75 62.5±0.75 2.7±0.0
Treatment 
12 hr
NCI-H520
Live Apoptotic Necrotic
Control 48.2±3.8 50.4±4.2 1.6±0.3
ImM PA 46.0±2.1 52.3±2.6 L7±0.4
2 mM MJ 25.0±0.1 74.1±0.5 0.8 m  1
Treatment 
12 hr
NCI-H2170
Live Apoptotic Necrotic
Control 90.7±0.05 8.6±0.2 0.7±0.1
ImM PA 90.4±0.05 8.7±0.05 0.8±0.1
2 mM MJ 86.8±0.0 11.8±0.05 1.4±G.G5
Cancer cells (1 x 10®) treated with PA or MJ for 12 hr and stained with Annexin V-FITC 
and PI and analyzed with FACSCalibur flow cytometer as described in the text. Values 
are Mean±SEM of duplicate analyses and p<0.005 from one way ANOVA analysis.
35
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 3: Expression of p53 protein in lung cancer cells treated with PA or MJ.
Treatment NCI-H520 NCI-H2170
(pg of p53/pg protein)
Control 3.34±0.004 37.69±0.17
ImM PA 3.67±0.006 85.44±0.31
2mM MJ 3.32±0.06 87.10±0.35
Quantitative levels of p53 protein were determined by ELISA 
technique according to the manufacturer’s instructions. Results 
are representative of duplicate analysis. Values are Mean±SEM 
and the P<0.001 for NCI-H520 and P<0.04 for NCI-H2170 cells.
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CHAPTER 4
JASMONATES INDUCE APOPTOSIS AND CELL CYCLE ARREST IN NON­
SMALL CELL LUNG CANCER LINES
4.1 Abstract
The jasmonates, cis-jasmone (CJ) and methyl jasmonate (MJ), were investigated for their 
effects against NSCLC cell lines A549 and H520. CJ or MJ inhibited the proliferation of 
both cell lines in a dose dependent manner as well as induced cell cycle arrest in the 
G2/M phase. Apoptosis was observed following treatment with CJ or MJ as indicated by 
Hoechst staining and confirmed by dual annexin V-FITC/PI and DAPI staining. p38 and 
ERKI/2 phosphorylation was observed with increased expression of bax, p21 and 
caspase-3 activity. These observations indicate that jasmonates may have a therapeutic 
value in the treatment of lung cancer.
4.2 Introduction
Lung cancer is the leading cause of cancer deaths in both men and women in the 
Western world. The estimated total cancer deaths in the U.S. in 2005 due to tobacco use 
were 175,000, accounting for 29% of all cancer deaths [1]. The two most common types 
of lung carcinomas are small cell and non-small cell carcinomas. The most common 
alteration in lung cancer is mutation of the p53 gene, which is associated with cigarette 
smoking and asbestos exposure [2]. The p53 tumor suppressor gene is mutated in >80%
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of small cell carcinoma and in about 50% of squamous cell carcinoma of the lung [2]. 
Wild-type p53 plays a major role in the suppression of tumor development by a 
mechanism of cell cycle arrest or apoptosis in cells subjected to genotoxic or 
nongenotoxic stresses [3-5]. Cells lacking the wild-type p53 gene are genetically 
unstable and are prone to tumor development [6, 7].
The p53 tumor suppressor gene is a direct transcriptional activator for p21 and the 
pro-apoptotic protein bax. Bax and Bcb belong to the Bel; family of proteins that are 
major determinants of cell viability. Bax functions by antagonizing the anti-apoptotic 
activities of Bclz [11]. The p53 protein is expressed in cancer cells exposed to stress and 
induces the expression of its downstream effector, bax, which permeabilizes the 
mitochondrial membrane to release cytochrome c [8]. Cytochrome c is released into the 
cytosol and forms the apoptosome complex ’with apaf-1 (apoptotic protease activating 
factor-1) and procaspase-9. The apoptosome then activates caspase-3 by cleaving the 
downstream procaspase-3, ultimately causing cell death [9, 10]. p53 induces the
expression of p21WAFl protein in functional p53 cells and p21 has also been shown to 
be expressed in non-functional p53 cells [12-14]. p21 is a universal inhibitor of cyclin- 
dependent kinases (cdk2/cdk4), thus causing cell cycle arrest at Go/Gi or G2/M phase [12- 
14].
Current treatment options for lung cancer include surgery, chemotherapy and 
radiation therapy or any combination of these modalities. Chemotherapy has an 
important role in small cell cancer treatment, but is often relegated to a palliative role for 
non-small cell cancers, due to limited efficacy, as well as toxicity or side effects. Hence,
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there is a need to develop novel medical therapies for the treatment of lung cancer, 
particularly the non-small cell type.
Several naturally occurring plant compounds with anti-tumor activities have been 
reported, though their mechanism(s) of action are not fully understood [15-18]. A novel 
class of plant compounds with anti-cancer effects is the jasmonates, consisting of over 25 
members including cis-jasmone (CJ) and methyl jasmonate (MJ) that are synthesized in 
plants in response to attack or injury [19]. The jasmonates have been reported to inhibit 
the growth of lung and prostate cancer cells cultured in vitro [18, 20, 21]. Although the 
mechanism of action of jasmonates is not yet fully understood, it has been reported that in 
A549 cells, they might act through the bax/bclx/s and reactive oxygen species production 
or through a direct action on the mitochondrial membrane in human T lymphoblastic 
leukemia cells [21, 22].
Mitogen activated protein kinases (MAPK) are activated in response to stimuli to 
determine cell fate. MAPK proteins signal cells to either inhibit or induce apoptosis 
depending on the cell type, stimuli and time of activation. MAPK pathway plays an 
important role by regulating a number of downstream molecules, kinases such as ERKl/2 
and p38, scaffold proteins and the balance between these molecules exerts cellular 
responses including cell proliferation, cell cycle arrest, migration, differentiation and 
apoptosis. It has been reported that MJ induced stress activated c-Jun N-terminal kinase 
and p38 MAPK in lymphoid cells [23].
We studied the effects of CJ and MJ on non-small cell lung cancer (NSCLC) cell 
lines H520 (human lung squamous cell carcinoma) and A549 (human lung 
adenocarcinoma). We found that these jasmonates inhibited the proliferation of both cell
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lines in a dose-dependent manner. The jasmonates increased the expression o f Bclz and 
p21 proteins, in both cell lines. Jasmonates also induced the expression o f Bax and 
increased the caspase-3 activity. We investigated the MAPK signaling mechanism in 
both cell lines exposed to MJ. We observed that MJ induced ERKl/2 phosphorylation in 
both cell lines. We also determined that p38 is phosphorylated in H520 cells but not in 
A549 at the time points studied. We conclude that the jasmonates induced apoptosis by 
activating MAPKs, bax and caspase-3 in lung cancer cells.
4.3 Materials and methods 
Chemicals and reagents 
Cell culture media (RPMI 1640 and Ham’s F-12K) were obtained from ATCC 
(Manassas, VA). Fetal bovine serum (FBS), penicillin (1000 units/ml) and streptomycin 
(1000 Dg/ml) (P/S) were purchased from Hyclone Laboratories (Logan, UT). Cis- 
jasmone (CJ), methyl jasmonate (MJ), protease inhibitors, propidium iodide (PI) and 
ribonuclease A (RNase A) were obtained from Sigma Chemical Company (St. Louis, 
MO). Phosphate buffered saline (PBS, lacking Ca^^ and Mĝ "̂ ) was purchased from 
Invitrogen Corporation (Grand Island, NY). Annexin V-FITC kit was obtained from BD 
Biosciences Pharmingen (San Jose, CA). Protein extraction buffer and alamarBlue were 
purchased from Biosource International, Inc. (Camarillo, CA). Sodium dodecyl sulfate, 
bisacrylamide, N,N,N,N*-tetramethylethylenediamine (TEMED) and ammonium 
persulfate were obtained from Bio-Rad Laboratories (Hercules, CA). Primary antibodies 
to p53, bax, bcL and p21, enzyme conjugated horse radish peroxidase (HRP), secondary 
antibodies and protein standards were obtained from Santa Cruz Biotechnology, Inc.
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(Santa Cruz, CA). ECL+ western blotting detection system was purchased from 
Amersham Biosciences (Piscataway, NJ). All other reagents and chemicals were o f the 
purest grade and were obtained from reputable vendors.
Cells and cell culture 
Human adenocarcinoma of the lung (A549) and human squamous cell carcinoma 
of the lung (H520) cell lines were obtained from ATCC (Manassas, VA). The cells were 
grown in appropriate medium supplemented with 10% FBS and 1% P/S until the plate 
was 80% confluent. The cells were dislodged by trypsinization, counted, and an 
appropriate number of cells were seeded for each experiment. Stock solutions (l.OM) of 
CJ or MJ were prepared by dissolving each in DMSO. Treatment concentrations were 
prepared by diluting the stock solution in culture medium, with occasional stirring, at 
37°C for 2 hr prior to use to insure the agents were dissolved. For the treatment, the 
culture medium was replaced with treatment medium containing the desired 
concentration of each agent and incubated at 37°C in humidified, 5% CO2 atmosphere. 
Cells in control plates received medium containing DMSO (0. 3% v/v).
Cvtotoxicity assav
The cytotoxic effects of CJ and MJ on human lung cancer cell lines were 
determined using the alamarBlue assay [24]. Reduction of the alamarBlue dye was foimd 
to be proportional to the number of viable cells. Cells (5x10^) were seeded in flat 
bottomed 96-well plates for 15-18 hr to undergo attachment. The culture medium was 
replaced with lOOpl of media containing varying concentrations of CJ or MJ and the cells 
exposed for 24 hr. At termination, the treatment medium in each well was replaced with 
lOOql of fresh medium and lOql of the alamarBlue dye. thus the assay only measures
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viability in adherent cells. The cells were incubated at 37°C in humidified 5% CO2 for 4 
hr. The fluorescence of the dye was measured at an excitation wavelength of 530nm and 
emission wavelength of 590nm using GENios fluorescence plate reader (PHENIX 
Research Products, Hayward, CA). Attached cell viability was calculated as follows:
Viability (%) = (FLT590 - Blk / FLU590 - Blk) xlOO 
FLT59o=Fluorescence of treatment group at 590nm 
FLU590- Fluorescence of untreated group at 590nm 
Blk= Blank
Colonv formation assav 
The long-term (delayed) cytotoxic effects of CJ or MJ on the lung cancer cells 
were determined using the colony formation assay (CFA) as previously described [18]. 
The cells were exposed to 0 or 2mM CJ or MJ for 24 hr after which the treatment 
medium was aspirated off and the cells washed twice with PBS and once with culture 
medium. Fresh, complete medium was then added and the cells were allowed to grow in 
humidified CO2 atmosphere at 37°C for 14 days. The medium was decanted, and the 
cells were washed with PBS and stained with crystal violet (0.5g/100ml in 95% ethanol). 
Colonies (>50 cells/colony) were counted and the percentage survival (% viability) was 
calculated relative to the control (100%) group.
Apoptotic assavs
DNA content analysis was performed to determine the effects of CJ and MJ on 
cell cycling in the cancer cell lines. Cells (1x10^) were seeded in 100mm tissue culture 
dishes and treated as described earlier. At termination, the cells were harvested, counted, 
washed with PBS and fixed in 90% ethanol. The cells were then stained with PI staining
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solution (100|ig/ml PI, 0.1% Triton X-100, and Img/ml RNase A (DNase-free) in PBS; 
1:1:1 by volume). Twenty thousand events were acquired on a FACSCalibur flow 
cytometer (Becton Dickinson, San Jose, CA). The percentage of the cells at different 
phases of the cell cycle was obtained using the DNA analysis software ModFit LT 3.0 
(Verity Software House, Topsham, ME).
Dual PI and annexin V-FITC staining was performed to confirm apoptosis 
induction by CJ or MJ in the cell lines. The transversion of phosphatidyl serine (PS) 
from the inner to the outer leaflet of the plasma membrane is an initial event in cells 
undergoing apoptosis and has been used to confirm apoptosis induction [25, 26]. Control 
or treated cells were harvested, washed, counted and stained with annexin-V FITC 
according to the manufacturer’s instructions (BD Pharmingen, San Jose, CA). Apoptotic 
and necrotic cells were differentiated by staining with a mixture of PI (500pg/ml) and 
annexin V-FITC solution (BD Pharmingen, San Jose, CA). Annexin V-FITC stains the 
pre-apoptotic and apoptotic cells while the PI stains the necrotic cells. Data on the 
fluorescence intensities of the cells were acquired with a FACSCalibur flow cytometry 
and analyzed using CellQuest analysis software (Becton Dickinson, San Jose, CA). 
Numeric quantization of the data was accomplished by population gating.
To further confirm apoptosis induction, we studied morphological changes that 
are characteristic of apoptosis in lung cancer cells exposed to the jasmonates. The cells 
were seeded in 8-well slides, exposed to 0 or 2mM CJ or MJ for 24 hr then the medium 
was aspirated off. One set of cells was stained with Hoechst dye (2Dg/ml) while another 
set was fixed with paraformaldehyde and stained with DAPl (4’, 6-diamidine-2’- 
phenylindole dihydrochloride, 0.2mg/ml). For the set stained with Hoechst dye, the
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medium was aspirated off and 50001 of the dye was added to the cells, incubated for 15 
min and observed under a fluorescence microscope (Nikon Instruments, Inc. Melville, 
NY). The number of cells in the bright field and Hoechst-stained cells were counted and 
the percentage of cells undergoing apoptosis was calculated as:
% Apoptosis = (Number of Hoechst positive cells/Number of cells in bright field) xlOO.
For cells stained with DAPI, morphological changes (blebbing, chromatin 
condensation and nuclear fragmentation) indicative of apoptosis were observed and the 
images acquired with the fluorescence microscope (Nikon Instruments, Inc. Melville, 
NY).
Protein extraction, western blotting and ELISA assavs 
The expression profiles of p53, bax and pro-caspase-3 proteins were determined 
using western blotting technique, while those of bclz and p21 proteins were determined 
using the ELISA technique. Control and treated cells were harvested, washed, pelleted in 
microfuge tubes and stored at -80*̂ C until analyzed. For protein extraction, 10001 of the 
extraction buffer (lOmM Tris, pH 7.4, lOOmM NaCl, ImM EDTA, ImM EOT A, ImM 
NaF, 20mM Na4Pz07, 2mM Na3V04, 1% Triton X-100, 10% glycerol, 0.1% SDS, 0.5% 
deoxycholate) containing proteinase inhibitor (250|xl/5ml) and PMSF (ImM) was added 
for every 1x10^ cells, with occasional mixing every 10 min for 30 min. The cell lysate 
was clarified at 13,000 rpm at 4°C for 10 min. The supernatant was collected, aliquoted 
into tubes and stored at -80°C. The total protein concentration was determined using the 
BCA protein assay kit (Pierce, Rockford, IL).
Aliquots (30 Og) of total protein were loaded, separated on SDS-PAGE and 
transferred to PVDF membrane. After blocking with 10% nonfat dry milk containing
47
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
0.05% Tween 20, the membrane was incubated with primary antibodies (1:1000) to p53, 
bax, bell, p21 (Santa Cruz Biotechnology, CA), caspase-3 (Pharmingen, San Jose, CA ) 
or D-actin (Sigma-Aldrich, St Louis, MO) for 2 hr at room temperature. The membrane 
was washed three times with western IX wash buffer (12.4 mM trizma, 37.4 mM NaCl,
0.5% TritonX-100, pH 7.4) and probed with HRP or with fluorescent (532 nm) secondary 
antibodies (1:1000). The signal was detected with ECL+ detection kit and visualized 
with a TYPHOON model 9410 (Amersham Biosciences, Piscataway, NJ). For proteins 
that had no detectable signals by western blot, we used the more sensitive ELISA 
technique to probe for the quantitative expression of bcL (Biosource International, Inc., 
Camarillo, CA) and p21 (Assay Designs, Inc. Ann Arbor, Ml) according to the 
manufacturers’ instructions.
Caspase-3 assav
Cells (0.5 X 10®) were plated in p i00 tissue culture dish, incubated overnight at 
37° C and exposed to CJ and MJ for 24hr. The cells were harvested with trypsin EDTA 
and washed once with PBS. Caspase-3 activity was measured according to 
manufacturer’s (Oncolmmunin, Inc. Gaithersburg, MD) instructions by using FACS 
Calibur flow cytometry.
MAPK assav bv ELISA 
p38 and ERKl/2 activity was determined by an ELISA assay kit (Super array, 
Frederick MD). Cells (1.5 X 10'*) were plated in a 96-well plate and incubated overnight 
in humidified 5% CO2 atmosphere at 37°C. The following day, cells were serum starved 
for 18-24 hr, exposed to MJ and assayed. Briefly, adherent cells were fixed to the plate, 
washed, blocked and incubated with a primary antibody followed by a secondary
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antibody. Then developing solution was added and the samples were incubated for 10 
min at room temp before the stop solution was added. Absorbance was measured at 450 
nm. Relative phosphorylation was normalized to cell number according to 
manufacturer’s instructions.
4.4 Statistical analysis 
The results were presented as Mean ±SEM of replicate analyses accompanied by 
the number of independent experiments. Statistical analyses were performed using t-test. 
Differences at p<0.05 or less are considered statistically significant.
4.5 Results
CJ and MJ inhibited the proliferation of lung cancer cells 
Both CJ and MJ inhibited the proliferation of lung cancer cells in a dose- 
dependent manner (Figure lA  and IB). The concentrations that inhibited cell 
proliferation by 50% (IC50) at 24 hr were 2.5mM (A549) and 2.2mM (NCI-H520) for CJ 
(Figure lA), and 2.0mM (A549) and 2.5mM (NCI-H520) for MJ (Figure IB) 
respectively. The effects of exposure to CJ or MJ for 24 hr were also evaluated using a 
colony formation assay (Figure 2). Compared to the controls, CJ significantly (p<0.01) 
inhibited the long-term proliferation of A549 cells by 50% and NCI-H520 by 75%, while 
exposure to MJ significantly (p<0.01) inhibited the long-term proliferation of A549 and 
NCI-H520 cells by 42% and 70% respectively (Figure 2).
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CJ and MJ induced cell cycle arrest and apoptosis in lung cancer cells
CJ and MJ induced a significant block at the G2/M phase of the cell cycle in both 
A549 (Figure 3B) and H520 (Figure 3C) cell lines accompanied by increased sub-diploid 
population. A typical result for a treatment group is shown in panel A. To confirm 
whether the observed cell death was as a result of apoptosis, we used dual annexin V- 
FITC (AV) and PI (flow cytometry), Hoechst and DAPI staining (fluorescence 
microscopy) techniques were used. For flow cytometric analysis, cells treated with CJ or 
MJ for 24 hr were stained with AV/PI and gated into the lower left (LL), lower right 
(LR), upper right (UR) or upper left (UL) quadrants based on their fluorescence 
intensities along the annexin or PI channels. Cells in the LL (low annexin, low PI) 
quadrant represented live cells; cells in UL (low annexin, high PI) quadrant were 
necrotic; cells in LR (high annexin, low PI) quadrant were in early apoptosis, while the 
cells in UR (high annexin, high PI) quadrant were not included in the analysis since these 
cells have a permeable membrane and hence are expected to easily bind annexin V. 
Apoptotic cells were calculated as cells in LR quadrant. Following CJ treatment the 
proportion of apoptotic cells was 9% in A549 (Figure 4A) and 24% in H520 (Figure 4B) 
cells. Cells treated with MJ had similar results for apoptosis 14% in A549 and 26% in 
H520 cells respectively (Figure 4A and 4B).
When cells were treated with CJ or MJ and stained with Hoechst or DAPI, results 
obtained by fluorescence microscopy showed that CJ and MJ induced apoptosis in the 
cell lines (Figure 5A and 5B). Exposure to CJ resulted in apoptotic population of 33% in 
A549 and 31% in H520 cells (Figure 5A). Similarly, MJ resulted in 4% and 14% 
apoptotic cells in A549 and H520 cell lines (Figure 5A) respectively. Staining with
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DAPI confirmed that CJ and MJ induced chromatin condensation, blebbing and nuclear 
fragmentation as well as morphological changes that are characteristic of apoptosis 
(Figure 5B) in the cells. The observed inhibition of proliferation was therefore possibly a 
result of cell cycle arrest at the G2/M phase, with apoptosis induction as a consequence of 
the cell cycle arrest.
Expression of p53. bax. bel? and p21 proteins in lung cancer cells 
The expression of proteins regulating cell cycle progression (p21) and apoptosis 
(Bax, and Bc^) were examined using western blotting and ELISA techniques (Table I 
and Figure 6). We exposed cells to lower concentrations (0.5mM) of jasmonates to obtain 
maximum number of cells for signaling mechanism. Although p53 was not detected, CJ 
or MJ treatments changed the level of bax by 25% (Figures 6A and 6B) in H520 cells. A 
decrease in the level of procaspase-3 was observed in CJ- and MJ-treated H520 cells 
(Figures 6A and 6B) compared to the control. Caspase-3 activity was increased in H520 
cells in the treatment groups, compared to the control, resulting in a shift in the peak in 
the treatment groups (Figure 6C 6D and 6E) as determined by flow cytometry (Figure 
6C). Increased expression of BCI2 in A549 and H520 cells was observed (Table 1). 
Exposure to 0.5mM CJ caused 32.7% (A549) and 16% (H520) increases respectively in 
Bcl2 (Table 1). Similarly cells treated with 0.5mM MJ observed increases were 25% in 
A549 and 4% in H520 (Table 1). Exposure to CJ and MJ increased the expression of p21 
protein in A549 and H520 cells (Table 1). Exposure to CJ elicited 166.4% (A549) and 
73% (NCI-520) increases in p21, while MJ caused 113% (A549) and 30% (NCI-H520) 
increases in the cell lines respectively (Table 1).
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MJ increased MAPK activity 
MAPK signaling mechanism was studied to determine the phosphorylation levels 
of p38 and ERKl/2. Increased ERKI/2 phosphorylation was observed in both A549 
(Figure 7A) and H520 (Figure 7B) cell lines exposed to 3mM MJ. MJ increased p38 
phosphorylation in H520 (Figure 7D) but not in A549 (Figure 7C) cell line at the time 
points investigated.
4.6 Discussion and conclusion 
Jasmonates, novel anticancer agents, have been reported to suppress the 
proliferation and induce cell death in prostate, melanoma, lung, lymphoma and leukemia 
cells [18, 20, 21]. The experiments presented here as well as previous studies 
demonstrated that the jasmonates inhibited the proliferation of NSCLC cell lines A549 
and H520 (Figure I). Survival assays showed that jasmonates inhibit the long-term 
proliferation and cell cycle analysis demonstrated a Ga/M block in both cell lines. 
Apoptotic studies using flow cytometry and fluorescent microscopy detected an increased 
amount of apoptotic cells in treatment groups compared to control even though the 
methods resulted in different values for apoptosis. These differences in the amount of 
apoptosis detected are most likely due to the techniques used. CJ and MJ induced 
apoptosis in similar signaling pathways by inducing the expression of Bax, Bela, p2I, 
activation of caspase-3 and phosphorylation of MAPK in both the cell lines. Both Bax 
(pro-apoptotic) (Figure 6) and Bcl2 (anti-apoptotic) (Table 1) levels increased in H520 
cells following treatment with MJ or CJ. Since apoptosis occurred in these cells the 
signals for apoptosis were higher then the ability of Bcl2 to inhibit this complex process
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or apoptosis was achieved by a mechanism that did not require mitochondrial 
involvement. To the best of our knowledge this is the first report of the signaling 
mechanism of CJ as well as its comparison with MJ. It is also the first report 
demonstrating that MJ can induce the expression of p2I in NSCLC cell lines.
Jasmonates may be good potential agents in the treatment of NSCLC. The results 
presented in this study indicate that MJ is capable of inducing cell cycle arrest, apoptosis 
and induced expression of pro-apoptotic proteins in NSCLC cell lines. These results are 
consistent with earlier studies [18,20-23]. At 0.5mM (a sub IC50 concentration) MJ was 
able to increase the expression of Bel: but an earlier study using S.OmM MJ reported no 
increased expression of Bela [22]. The difference in these results is most likely due to the 
concentration of MJ used. CJ had very similar effects to MJ, which was expected due to 
the similarity in their structures. Earlier studies on MAPK using MJ reported the 
phosphorylation of these kinases in A549 and leukemia cells, the results obtained here are 
consistent with their reports (Figure 7) [22, 23]. However, apoptosis induction in A549 
was not regulated by MAPKs [22]. These results indicate the ability of jasmonates to be 
effective agents against lung cancer.
The use of NSCLC cell lines provides a useful model system in which to examine 
the effects of cytotoxic agents. A549 and H520 are two cell lines that have been used for 
such studies. One major difference between these two cell lines is the expression of p53 
which is functional in A549 and non-functional in H520. p53 is a transcription factor for 
p2I and the BcL family of proteins [6-8]. The difference in p53 function would lead to 
the prediction that H520 cells should be more resistant to agents that induce apoptosis. A 
study using UV radiation reported that H520 cells were indeed more resistant than the
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A549 cell line [27]. However, a recent study using ionizing radiation reported A549 cells 
were more resistant than H520 [28]. The studies reported here also indicate that the 
A549 cell line is more resistant than the H520 cell line. Table 1 clearly indicates that the 
level of Bcl2 in H520 cells is higher than in A549 cells under all conditions investigated. 
Therefore, the greater sensitivity of H520 to jasmonates is not dependent on the level of 
Bcl2. Another interesting difference between the A549 and H520 cell lines is the 
response of p38 to MJ. Figure 7 shows that in the H520 cells p38 phosporylation 
increases two hours after exposure while in the A549 cells the phosphorylation decreases 
for at least eight hours after exposure. p38 is a MAPK that has a wide variety of 
biological effects including the ability to phosphorylate p53 and increase its activity. So 
even though A549 cells express a wild-type p53 if it is not phosphorylated it may not be 
playing a major role in the apoptotic signaling pathway, perhaps providing resistance to 
the A549 cells.
p21 is a universal inhibitor of CDKs/cyclins that induces cell cycle arrest. An 
increased level of p21 was observed in treatment groups (Table 1), which correlates with 
the cell cycle arrest in both cell lines (Figure 3). Increased p21 levels are higher in A549 
than in H520 (Table 1) which may explain the cell cycle arrest at Gq/G i (Figure 3B) 
along with Gz/M (Figure 3B). These results indicate that p21 may be a unique target in 
NSCLC, which could stop the proliferation of these cancer cells.
Lung cancer was the leading cause of cancer deaths in the US, among both men 
and women, in 2005. NSCLC accounts for more than 80% of all lung cancer cases and 
has an overall survival at 5 years of less than 15% [29, 30]. Surgical resection is 
recommended for NSCLC but since more than half of patients present with advanced
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disease, complete surgical resection is not possible [31]. Therefore, the need to develop 
effective chemotherapies for NSCLC is paramount. The results presented here indicate 
that the jasmonates may be useful chemotherapeutic agents in the treatment of NSCLC. 
Currently, combination chemotherapy is given to NSCLC patients following surgery. 
Clearly, future studies will be needed to determine the efficacy of adding jasmonates to 
the NSCLC chemotherapy cocktail.
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4.9 Figure legends
Figure I : Cytotoxicity of CJ and MJ was determined in human lung cancer cells (A549 
and NCI-H520) in culture. Panel A: Cells were exposed to varying concentrations of CJ 
for 24 hr and the effects on cell viability assessed by mitochondrial dehydrogenase assay 
using alamarBlue dye as described in methods section. Panel B: Cells were exposed to 
different concentrations of MJ and the cell viability was determined. Cell viability was 
calculated as a percentage of untreated cells (100%). Values were Mean OSD (n=6); 
results are representative of three independent experiments. At concentrations 1.5mM 
and higher, there was a significant (p<0.001, one-tailed t-test) decrease in the viability of 
A549 and H520 cells compared to the control.
Figure 2: CJ and MJ inhibited the long-term proliferation of lung cancer cells. A549 and 
H520 cells were exposed to CJ or MJ for 24 hr, the drugs were washed off and the effects 
on long-term cell proliferation were determined. Colonies (>50 cells/colony) were 
counted and the percent survival was calculated as percentage of the control cells (100%).
59
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Values are MeanDSEM; results are representative of two separate experiments of 
duplicate analyses. CJ and MJ significantly inhibited the long-term proliferation of A549 
( t  p<0.01, one-tailed t-test) and H520 (* p<0.001, one-tailed t-test) lung cancer cells. 
Figure 3; CJ and MJ induced cell cycle arrest in lung cancer cells. Cells (1.0x10®) were 
exposed to 2mM CJ or 2mM MJ for 24 hr and cell cycle distribution was determined with 
FACSCalibur flow cytometry as described in the materials and methods. Values are 
MeanDSEM of triplicate analyses. Data are representative of three different 
experiments. Statistical analysis was performed by two-tailed t-test and significant (# 
p<0.05). A representative flow cytometer printout from A549 cells treated with 2.0 mm 
MJ for 24 hrs and analyzed with ModFit 3.0 software is shown in panel A. A G2/M 
block was observed in both A549 (Panel B) and H520 (Panel C) with significant increase 
in apoptotic population compared to the control (# p<0.05).
Figure 4: Apoptosis induction by CJ and MJ was determined by Annexin-V FITC. Live, 
apoptotic and necrotic cells were analyzed using a FACSCalibur flow cytometry as 
described in the materials and methods. Apoptotic cells were calculated as the percent of 
cells in the lower right quadrant. The results are representative of two different 
experiments of duplicate analyses and values are represented as MeanDSEM. Panel A: 
In A549 CJ and MJ increased the proportion of apoptotic cells (f p<0.01, one-tailed t- 
test). Panel B: Significant increase in apoptotic cells was observed with CJ and MJ 
compared to the control in H520 cells ( t  p<0.01, one-tailed t-test).
Figure 5: CJ and MJ induced apoptosis in A549 and H520 cell lines. These cell lines 
were exposed to 2mM CJ or 2mM MJ for 24 hr and stained with Hoechst or DAPI as 
described in the materials and methods. Panel A: The percentage of Hoechst positive
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cells with morphological changes for apoptosis. The results are representative of two 
separate experiments done in duplicates and values are represented as MeanDSEM. CJ 
and MJ induced significant amount of apoptosis in A549 (# p<0.05, one tailed t-test) and 
H520 ( t p<0.01, one tailed t-test) cells. Panel B: DAPI staining showed chromatin 
condensation and nuclear fragmentation the hallmarks of apoptosis in treatment groups 
both in A549 and H520 cells. Arrow shows chromatin condensation and nuclear 
fragmentation.
Figure 6: Panel A: Representative Western blot of p53 (MW 53 kDa), bax (MW 22 kDa) 
and procaspse-3 (MW 36 kDa) expression in H520 cells. Bax expression is increased in 
treatment groups and Pro-caspase-3 levels are decreased in treatment groups. Panel B: 
Densitometry analysis showed an increased bax and decreased levels of procaspase-3 
compared to the control in H520. The percentage change in protein levels compared to 
the control was calculated as (treatment-control)Zcontrol x 100. Panel C, D and E: Flow 
cytometry analysis determined increased caspase-3 activity by CJ (D) or MJ (E) in H520 
cells as shown by the shift in histograms.
Figure 7: MAPK activity was determined by cell based assay with 3mM MJ by exposing 
to various time points in both cell lines. Values are MeanDSEM and statistical analyses 
showed significant difference between control and treatment. Panel A: In A549 cells 
increased phophorylation of ERKl/2 was observed with 3mM MJ starting from 30 min 
and decreasing after that ( t  p<0.01). Panel B: H520 cells treated with 3mM MJ also 
showed increased ERKl/2 activity initiating at 30 min and declining after that ( t  p<0.01). 
Panel C: p38 activity was lower in treatment groups in A549 than in control. Panel D: 
H520 cells showed increased p38 activity starting at 2 hr and declining by 8 hr (# p<0.05)
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Table 1 ; Expression of Bclz and p21 in lung cancer cell lines treated with CJ and MJ.
Treatment
Bclz p21
pg/1 X 10“* cells pg/1 X lO"* cells
A549 Control 
A549 O.SmMCJ 
A549 O.SmMMJ
76.1 D 0.002 
101.0D0.04^ 
95.200.04"
15.800.08
42.100.07"
33.700.08"
H520 Control 
H520 O.SmMCJ 
H520 O.SmMMJ
108.100.01
126.900.02®
112.7D0.01®
1.5D0.0 
2.6 00.02® 
2.000.005®
Values are presented as MeanDSEM. The p-values for one-tailed t-test: a = p<0.001, b
p<0.01.
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CHAPTER 5
PERILLYL ALCOHOL AND PERILLIC ACID INDUCED CELL CYCLE ARREST 
AND APOPTOSIS IN NON SMALL CELL LUNG CANCER CELLS.
5.1 Abstract
Plant products such as perillyl alcohol have been reported to possess anti-tumor activities 
against a number of human cancers though the mechanism of action has not yet been 
elucidated. The effects of Perillyl alcohol (POH) and its metabolite Perillie acid (PA) on 
the proliferation of non-small cell lung cancer (NSCLC, A549 and H520) cells were 
investigated. Both POH and PA elicited dose-dependent cytotoxicity, induced cell cycle 
arrest and apoptosis with increasing expression of bax, p21 and caspase-3 activity in both 
the cell lines. Combination studies revealed that exposing the cells to an IC50 
concentration of POH or PA sensitized the cells to cisplatin and radiation in a dose 
dependent manner. These results indicate that POH and PA in combination therapy may 
have chemotherapeutic value against NSCLC.
5.2 Introduction
Lung cancer is the leading cause of cancer deaths in the US among both men and 
women. Non small cell lung cancer (NSCLC) accounts for more than 80% of all lung 
cancer cases and has an overall survival at 5 years of less than 15% [1, 2]. Current 
treatment options for lung cancer include surgery, chemotherapy and radiation therapy.
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Surgery is recommended but complete surgical resection is not always possible because 
most patients present with advanced disease [3]. Hence, there is a need to develop 
effective chemotherapy against NSCLC.
Perillyl alcohol (POH) is a naturally occurring monoterpene found in essential 
oils of mints, cherries, lavenders, lemongrass, sage, cranberries, perilla, wild bergamot, 
gingergrass, savin, caraway and celery seeds [4-6]. POH is a hydroxylated product of d- 
limonene formed by the condensation of two isoprene units. POH is 5 to 10 times more 
lethal than limonene and has shown chemo preventive and therapeutic activity in DMBA- 
induced mammary cancer [7]. POH inhibited 4-(methyl-nitrosoamino)-1 -(3-pyridyl)-1 - 
butanone (NNK) induced mouse lung tumoregenisis, prevented the azoxymethane 
(AOM)-induced rat colon tumor models, inhibited diethyl-nitrosamine (DEN)-induced rat 
liver tumors and showed anti-tumor activity against pancreatic tumor models [8-13]. 
POH also inhibited the growth of human breast, colon, lung, murine glial, and hamster 
pancreatic ductal adenocarcinoma cells in vitro [14-19].
POH readily metabolizes to perillie acid (PA) and dihydroperillic acid (DHPA) in 
animals, whereas in humans, PA is the major circulating metabolite [20-22]. POH and 
PA inhibit the protein prenylating enzymes, protein famesyl transferase and 
geranylgeranyl transferase. PA and POH also cause cell cycle arrest at the GO/Gl phase 
[23, 24]. POH has been reported to regulate gene expression in lung cancer cells. POH 
also increased the expression of bax, bid and p21'^^^ , induced apoptosis and cell cycle 
arrest as well as decreased cyclin D and cdk2 expression without changing the levels of 
p53 [16]. PA has been shown to inhibit the proliferation of lung cancer cells H322 and 
H838 with an increase in caspase-3 activity and cleavage of PARP. DNA microarray
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studies showed that a large number of genes changed expression in these two cell lines, 
but analysis suggested that POH may mediate its effects via posttranslational 
modifications [16]. Pretreatment of prostate as well as head and neck cancer cells with 
POH sensitized the cells to radiation [25,26].
Apoptosis is a process regulated by specific genes and occurs through two major 
pathways, extrinsic and intrinsic, in mammalian cells [27]. The extrinsic pathway 
involves signals transduced through death receptors while the intrinsic pathway involves 
proteins of the Bcb family. Bax is an apoptotis inducing protein of the Bela family and 
its homodimerization or heterodimerization with Bela determines whether or not 
apoptosis will occur [28]. Direct activation of bax on the outer mitochondrial membrane 
renders the membrane permeable and results in release of cytochrome c. Cytochrome c 
forms an apoptosome complex with apaf-1 and caspase-9 in the cytosol which activates 
procaspase-3 to caspase-3. The protein p21 is a universal inhibitor of cyclin dependent 
kinases (CDKs) that are involved in cell cycle progression along with specific cyclins (B 
or D or E) [29-33].
POH and PA have been reported to inhibit the proliferation of lung cancer cells 
[14-16]; however, PA’s mechanism of action remains unknown. We studied the effects 
of PA and POH on non-small cell lung cancer (NSCLC) cells and demonstrated that POH 
and PA inhibited the growth of lung cancer cells. Cells treated with PA and POH showed 
long-term proliferation inhibition and increased sensitivity to cisplatin and radiation. 
POH and PA induced cell cycle arrest and apoptosis in lung cancer cells. We observed 
increased expression of Bela, bax, p21 and caspase-3 activity in cells treated with POH 
and PA. We conclude that POH and PA induced apoptosis via a caspase-3 pathway.
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5.3 Materials and methods 
Chemicals and reagents 
Cell culture media (RPMI 1640 and Ham’s F-12K) was obtained from ATCC 
(Manassas, VA). Fetal bovine serum (FBS), penicillin (1000 units/ml) and streptomycin 
(1000 Dg/ml) (P/S) were purehased from Hyclone Laboratories (Logan, UT). Perillie 
acid (PA), perillyl alcohol (POH), protease inhibitors, propidium iodide (PI) and 
ribonuclease A (RNase A) were obtained from Sigma Chemical Company (St. Louis, 
MO). Phosphate buffered saline (PBS, lacking Ca^  ̂ and Mg^^) was purchased from 
Invitrogen Corporation (Grand Island, NY). Annexin V-FITC kit was obtained from BD 
Biosciences Pharmingen (San Jose, CA). Protein extraction buffer and alamarBlue were 
purchased from Biosource International, Inc. (Camarillo, CA). Sodium dodecyl sulfate, 
bisacrylamide, N,N,N,N*-tetramethylethylenediamine (TEMED) and ammonium 
persulfate were obtained from Bio-Rad Laboratories (Hercules, CA). Primary antibodies 
to Bela, bax, and p21, enzyme conjugated horse radish peroxidase (HRP), secondary 
antibodies, and protein standards were obtained from Santa Cruz Biotechnology, Inc. 
(Santa Cruz, CA). ECL plus western blotting detection system was purchased from 
Amersham Biosciences (Piscataway, NJ). All other reagents and chemicals were of the 
purest grade and were obtained from reputable vendors.
Cells and cell culture 
Human adenocarcinoma (A549) and squamous cell careinoma (H520) of the lung 
were obtained from ATCC (Manassas, VA). The cells were grown in appropriate 
medium supplemented with 10% FBS and 1% P/S until the plate was 80% confluent. 
The cells were dislodged by trypsinization, counted and the appropriate number of cells
73
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
seeded for each experiment. Stock solutions (IM) of PA or POH were prepared by 
dissolving each in DMSG and then were filter sterilized. The indicated treatment 
concentrations were prepared by diluting the stock solution in culture medium, with 
occasional stirring at 37°C for 2 hr. For the treatment, the culture medium was replaced 
with treatment medium containing the desired eoncentration of each agent and incubated 
at 37°C in humidified, 5% CO2 atmosphere. Cells in control plates were supplemented 
with medium containing DMSG (00.3% v/v).
Cvtotoxicitv assav
The cytotoxic effects of PA or PGH on human lung cancer cell lines were 
determined using the alamarBlue assay [34, 35]. Reduction of the alamarBlue dye is 
proportional to the number of viable cells. Cells (5x10^) were seeded in flat bottomed 
96-well plates for 15-18 hrs to undergo attachment. The culture medium was replaced 
with lOOpl of media containing (0, 0.5, 1.0, 1.5, 2.0, 2.5 and 3.0 mM) concentrations of 
PA or (0, 0.5,1.0, 1.5, and 2.0 mM) concentrations PGH and the cells exposed at 37°C in 
humidified 5% CG2 for 24 hrs. At termination, the treatment medium in each well was 
replaced with lOOpl of fresh medium and lOpl of the alamarBlue dye. The cells were 
incubated at 37°C in humidified 5% CG2 for 4 hrs. Fluorescence was measured at an 
excitation wavelength of 530 nm and emission wavelength of 590 nm using GENios 
fluorescence plate reader (Tecan Systems Inc. San Jose, CA). Cell viability was 
calculated as follows:
Viability (%) = (FLT590 - Blk / FLU590 - Blk) xlOO 
FLT59o=Fluorescence o f  treatment group at 590nm 
FLU59o= Fluorescence o f  untreated group at 590nm
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Blk= Blank
Colony formation assav 
The long-term (delayed) cytotoxic effects of PA, POH or a combination of these 
agents with cisplatin or ionizing radiation on lung cancer cells were determined using the 
colony formation assay (CFA) as described previously [15]. The cells were exposed to 0, 
1, 2, 3, 4, and 5 mM concentrations of PA or 0, 0.5, 1.0, 1.5 and 2.0 mM concentrations 
of POH for 24 hrs. In combination studies, cells were exposed to the 1C50 concentration 
of PA (3.6 mM) or POH (1.4 mM) for 24 hrs followed by treatment with cisplatin for 1 hr 
or ionizing radiation (1, 3, 5 and 6 Gy), after which the treatment medium was aspirated, 
cells washed with PBS, harvested with trypsin, counted, plated into three 60mm dishes 
and incubated in humidified 00% atmosphere at 37°C for 14 days. The medium was then 
decanted and cells stained with crystal violet (0.5g/100ml in 95% ethanol). Colonies 
(>50 cells/eolony) were counted and the percentage survival (%viability) was calculated 
relative to the control (100%) group.
Apoptotic assays
DNA content analysis was performed to determine the effects of 2.0 mM PA or
2.0 mM POH on cell cycling in the cancer cell lines. Cells (1x10®) were seeded in 100 
mm tissue culture dishes and treated as described earlier. At termination, cells were 
harvested, counted, washed with PBS, fixed in 90% ethanol and stored at 4°C. The cells 
were then stained with PI staining solution (lOOpg/ml PI, 0.1% Triton X-100, and 
1 mg/ml RNase A (DNase-free) in PBS; 1:1:1 by volume). Two thousand events were 
acquired on a FACSCalibur flow cytometer (Becton Dickinson, San Jose, CA). The
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percentage of the cells at different phases of the cell cycle was obtained using the DNA 
analysis software Modfit LT 3.0 (Verity Software House, Topsham, ME).
To confirm apoptosis induction by PA and POH, a dual PI and annexin V-FITC 
assay was performed. The transversion of phosphatidylserine (PS) from the inner to the 
outer leaflet of the plasma membrane is an initial event in cells undergoing apoptosis and 
has been used to confirm apoptosis induction [36, 37]. Control or treated cells were 
harvested, washed, counted, and stained with annexin-V FITC according to the 
manufacturer’s instructions (BD Pharmingen, San Jose, CA). Apoptotic and necrotic 
cells were differentiated by staining cells with a mixture of PI (500pg/ml) and annexin V- 
FITC solution (BD Pharmingen, San Jose, CA). Annexin V-FITC stains the pre- 
apoptotic and apoptotic cells while PI stains necrotic cells. Data on the fluorescence 
intensities of the cells were acquired with a FACSCalibur flow cytometer and analyzed 
using CellQuest analysis software (Becton Dickinson, San Jose, CA). Numeric 
quantification of the data was accomplished by population gating.
To detect the morphological changes characteristic of apoptosis, cells were seeded 
in 8-well slides and exposed to 0 or 2mM PA or POH for 24 hrs. At termination the 
medium was aspirated, the cells fixed with paraformaldedyde and stained with DAPI (4’, 
6-diamidine-2’-phenylindole dihydrochloride, 0.2mg/ml). For Hoeehst 33342 (20g/ml 
Hoechst) staining the medium was aspirated and 50001 of stain was added to the cells 
and incubated for 15 min. Morphological changes (cell blebbing, chromatin 
condensation and nuclear fragmentation) indicative of apoptosis were observed and the 
images acquired with fluorescence microscopy (Nikon Instruments Inc. Melville, NY).
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The number of cells in the bright field and Hoechst-stained cells were counted and the 
percentage of cells undergoing apoptosis was calculated as:
% apoptosis = (Number of Hoechst positive eells / Number of cells in bright field) xlOO.
Protein extraction, western blotting and ELISA assays
The expression profiles of BcL, and p21 proteins were determined using ELISA 
while western blotting techniques were used to measure the levels of bax and procaspase-
3. Control and treated cells (0.5 mM PA or POH exposure for 24 hrs) were harvested, 
washed, pelleted in microfiige tubes and stored at -80^C. For protein extraction, IGODl of 
the extraction buffer (lOmM Tris, pH 7.4, lOOmM NaCl, ImM EDTA, ImM EOT A, 
ImM NaF, 20mM Na4P20?, 2mM Na3VÜ4, 1% Triton X-100, 10% glycerol, 0.1% SDS, 
0.5% deoxycholate) containing protease inhibitor (250pl/5ml) and PMSF (ImM) was 
added for every 1x10® cells, with occasional mixing every 10 min for 30 min. The cell 
lysate was clarified at 13,000 rpm at 4°C for lOmin. The supernatant was collected, 
aliquoted into tubes and stored at -80°C. Total protein concentration was determined 
using a BCA protein assay kit (Pierce, Rockford, IL).
Equal amounts (30 Og) of total protein were loaded, separated on SDS-PAGE and 
transferred to a PVDF membrane. After blocking with 10% nonfat dry milk containing
0.05% Tween 20, the membrane was incubated with primary antibodies (1:1000) to bax, 
and procaspase-3 (Pharmingen, San Jose, CA) or Dactin (Sigma Aldrich, St Louis, MO) 
for 2 hrs at room temperature. The membrane was washed three times with western wash 
buffer (12.4 mM trizma, 37.4 mM NaCl, 0.5% TritonX-100, pH 7.4) and probed with 
HRP or fluorescent (532nm) secondary antibodies (1:1000). The membranes probed with 
HRP signal were detected with ECL plus detection kit and visualized with a Typhoon
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9410 (Amersham Biosciences, Piscataway, NJ) phosphoimager. The more sensitive 
ELISA technique for the quantitative determinations of Bclz (Biosouree International, 
Inc., Camarillo, CA) and p21 (Assay Designs Inc. Ann Arbor, MI) were used according 
to the manufacturers’ instructions.
5.4 Statistical analyses 
The results were represented as Mean ± SEM of duplicate analyses accompanied by a 
number of independent experiments. Statistical analysis was performed using t-test 
(Graphpad Software INC., CA, USA and Excel). Differences at p<0.05 or better were 
considered statistically significant.
5.5 Results
POH and PA induce cell death in luns cancer cells 
POH inhibited the proliferation of A549 and H520 lung cancer cells in a dose- 
dependent manner while PA did not (Figure 1). The concentration of POH at which 50% 
of cell proliferation was inhibited following a 24 hrs exposure was 1.7mM in H520 cells 
(Figure IB). The coneentrations of POH at 1.0 mM and above were all statistically 
significant from the control values in both the A549 (p = 0.01) and H520 (p = 0.004) cell 
lines. The long-term proliferation inhibition of A549 cells evaluated by a survival assay 
revealed that both POH and PA resulted in decreased survival in a dose dependent 
manner with POH being more lethal than PA (Figure 2A). The IC50 values (50% 
survival) were 1.4 mM and 3.6 mM for POH and PA respectively (Figure 2A). In 
combination studies, cells were first treated with the IC50 PA or IC50 POH
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concentrations followed by cisplatin or radiation. Cells treated with IC50 concentrations 
of POH or PA were more sensitive to cisplatin or radiation treatments compared to 
cisplatin or radiation alone (Figure 2B and 2C). Cisplatin (IxlO'"^ M) alone did not have 
an effect on cell survival, however, if the A549 cells were first treated with the IC50 
dose of PA or POH, survival decreased to 30 or 40% respectively (Figure 2B). Similarly, 
a five Gy dose of radiation resulted in 60% survival but if the cells were first treated with 
the IC50 dose of PA or POH, survival fell to 20 or 40% respectively (Figure 2C).
POH and PA induced cell cycle arrest and apoptosis in lung cancer cells 
PA induced S-phase arrest while POH induced Gq/G i arrest in A549 cells (Table 1). 
POH and PA induced Gz/M arrest in H520 cells after 24hrs exposure (Table 1). 
Apoptosis induced by POH or PA was determined by flow cytometrie analysis using a 
biotin-conjugated Annexin-V (AV)/PI and Hoechst stain. Cells were treated with 2.0 
mM POH or 2.0 mM PA for 24 hrs, stained with AV/PI and gated into lower left (LL, 
low annexin and low PI), upper left (UL, low annexin, high PI), lower right (LR, high 
annexin and low PI) and upper right (UR, high annexin and high PI) quadrants. The cells 
in LL were considered live and the cells in UL were necrotic. The cells in LR and UR 
were considered to be in early and late apoptosis respectively. Apoptotic cells were 
calculated as the sum of the LR and UR quadrants. The percentage of apoptotic cells in 
both A549 and H520 were 12% (control) while PA treatment increased apoptosis to 27% 
in A549 (Figure 3A) and to 18% in H520 cells (Figure 3B). POH treatment resulted in 
37% apoptotic cells in A549 (Figure 3A) and 48% apoptotic cells in H520 (Figure 3B). 
PA and POH treatments resulted in a statistically significant (p < 0.01) increase in 
apoptosis in both cell lines. Neither treatment produced necrosis in either cell line.
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POH and PA treated cells were stained with Hoechst 33342 as described in the materials 
and methods section. Morphological changes of apoptosis observed with fluorescence 
microscopy revealed that POH and PA induced nuclear condensation, blebbing and 
nuclear fragmentation as shown in Figure 5. Exposure to 2.0 mM PA resulted in 10% 
apoptosis in A549 and 31.5% in H520 cells while treatment with 2.0 mM POH resulted 
in 24% apoptosis in A549 and 60% in H520 cells (Table 2).
Bax, bel?. p21 and caspase-3 proteins were up-regulated in POH or PA treatments in lune
cancer cells
ELISA, western blotting and flow cytometric techniques were used to determine the level 
of proteins that were involved in cell cycle arrest and apoptosis (Table 3 and Figure 4). 
Cells were exposed to a lower concentration (0.5mM) of agents to obtain the maximum 
number of cells for analysis. In both cell lines PA or POH increased the expression of 
Bela, and p21 (Table 3). Exposure to PA induced 18% (A549) and 17% (H520) increases 
in Bela expression while POH increased Bela expression by 50% in A549 and 5% in 
H520 cells (Table 3). The protein p21, a universal inhibitor of cyclin dependent kinases 
involved in cell cycle arrest was inereased by PA or POH treatments in both cell lines. 
PA induced 61% (A549) and 100% (H520) increases in p21 expression while POH 
increased p21 expression by 50% in H520 cells (Table 3). Expression of bax and 
procaspase-3 in H520 cells shows both agents were capable of inducing bax expression 
and both decreased expression levels of procaspse-3 (Figure 4A). Flow cytometric 
analysis of caspase-3 showed a shift towards the right in POH or PA treated cells 
indicating increased caspase-3 activity (Figure 4B, 4C and 4D). The results confirm that 
treatment with POH or PA results in cell cycle arrest by increasing expression of p2I and
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induced apoptosis in a mitochondrial mediated pathway by increasing the expression of 
bax and caspase-3 activity.
5.6 Discussion and conclusion 
Monoterpenes have been reported to possess chemotherapeutic and chemo preventive 
activities against cancer cells. In vitro studies reported that POH inhibited the growth of 
pancreatic, breast and lung cancer cells [14-19]. To determine the chemotherapeutic 
effects of POH and PA, proliferation and apoptotic assays were used. This study showed 
that POH caused growth inhibition in a dose dependent manner in NSCLC cells. PA and 
POH showed long-term proliferation inhibition in A549 cells in vitro. Pretreatment with 
either PA or POH in A549 cells resulted in a greater sensitivity to cisplatin and radiation. 
Both PA and POH induced cell cycle arrest and apoptosis as well as increased the 
expression of Bcb, bax, p21 and activation of caspase-3.
POH is currently being tested in clinical trials, though its mechanism of action has 
not been firmly established. POH and PA may be potential agents for lung cancer 
treatment. The results presented here indicate that both agents are capable of inhibiting 
cell growth, inducing cell cycle arrest and apoptosis as well as increasing the expression 
of pro- and anti-apoptotic proteins in NSCLC cells. The results are consistent with 
earlier reports [14-19]. Earlier studies with POH on NSCLC cells (H322 and H838) 
showed the highest percent of eell death after 5 days and the appearance of apoptotic 
cells within 24-48 hrs [16]. Increased caspase-3 activity as well as up and down 
regulation of cell cycle genes were also observed, which suggested that POH effects are 
via post translational modifications [16]. An earlier report showed increased expression
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of cod inhibitor p21 and cycling E in colon cancer cells, while our study on lung cancer 
cells also showed increased expression of p21 (Table 3). The results indicate that 
observed cell cycle arrest is most likely due to increased expression of p21 (Table 3) and 
also suggests PA or POH as promising chemotherapeutic agents against NSCLC.
Studies on NSCLC indicate that plant compounds may be useful in adjuvant therapy. A 
study using POH and PA on head and neck cancer cells (HTB-43 and SCC-25) showed 
increased sensitivity to low dose radiation (lor 2Gy) treatment [25]. In this study, IC50 
concentrations of POH or PA sensitized A549 eells to cisplatin or radiation in a dose 
dependent manner. Both cisplatin and ionizing radiation have DNA as their critical 
target. While the specific mechanism whereby the increased cell killing occurs is 
unknown, it is interesting to speculate that the monoterpenes may be able to act at 
multiple sites not only activating apoptosis signaling pathways but perhaps also being 
able to inhibit DNA repair. Monoterpenes could be effective agents in chemo-radiation 
therapy of NSCLC but further studies will be needed to optimize these agents in 
combination therapy.
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5.9 Figure legends
Figure 1: Cytotoxicity of PA and POH was determined in human lung cancer cells (A549 
and NCI-H520) in culture. Panel A; Cells were exposed to various concentrations of PA 
for 24 hrs. The effects on cell viability were assessed by mitochondrial dehydrogenase 
assay using alamarBlue dye as described in the methods section. Panel B: Cells were 
exposed to various concentrations of POH and the cell viability was determined. Cell 
viability was calculated as a percentage of untreated cells (100%). Values were 
Mean±SD (n=6); results are representative of three independent experiments. At 
concentrations of 0.75 mM and higher, POH significantly (p<0.001, one-tailed t-test) 
decreased the viability of A549 and H520 cells compared to the control. Treatment with 
PA at 2.5 and 3.0 mM resulted in significant (p<0.05) decreases in cell viability. 
Figure 2; Long term proliferation of PA and POH alone or in combination with cisplatin 
or ionizing radiation in A549 cells. Panel A: A549cells treated with POH or PA for 
24hrs. Panel B; A549 cells were treated with cisplatin for 24 hrs (open circles) or with 
the IC50 dose of either PA (filled downward triangle) or POH (filled upward triangle) for 
24 hrs followed by cisplatin. Panel C: A549 cells were treated with ionizing radiation 
(filled circles) or with the IC50 dose of either PA (filled downward triangle) or POH 
(filled upward triangle) for 24 hrs followed by ionizing radiation. Values are 
Mean+SEM; results are representative of two separate experiments of triplicate analyses. 
PA and POH and combination of PA or POH with cisplatin or radiation significantly 
inhibited the long-term proliferation of A549 cells (fp<0.01, one-tailed t-test). 
Figure 3; Apoptosis induction by PA and POH was determined by Annexin-V FITC. 
Live, apoptotic and necrotic cells were analyzed using a FACSCalibur flow cytometry as
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described in the materials and methods. The results are representative of two different 
experiments of duplicate analyses and values are represented as MeanlSEM. Panel A: In 
A549 PA (* p<0.05) and POH (tp<0.01) increased the proportion of apoptotic cells. 
Panel B: Significant increase in apoptotic cells was observed with PA (* p<0.05) and 
POH (tp<0.01) compared to the control in H520 cells.
Figure 4: Panel A: Representative Western blot of bax and procaspse-3 expression in 
H520 cells. Bax expression is increased in the treatment groups while procaspase-3 levels 
are decreased in the treatment groups. Panels B, C and D: Flow cytometry analysis 
determined increased caspase-3 activity by PA (Panel C) or POH (Panel D) in H520 cells 
as shown by the shift in histograms eompared to the eontrol (Panel B).
Figure 5: Representative photographs of A549 and H520 cells treated with 2mM PA and 
2mM POH for 24 hrs. Cells were stained using Hoechst and the fluoreseence microscopy 
images were acquired as described in the methods. Panels A and B are images of the 
same field of A549 cells. Panel A is the bright field image and Panel B is the image taken 
with a UV emission filter. Panels C and D are images of the same field of H520 cells. 
Panel C is the bright field image and Panel D is the image taken with UV emission filter. 
Panels E and F are images of the same field of A549 cells treated with 2mM PA. Panel E 
is the bright field image and Panel F is the image taken with a UV emission filter. Panels 
G and H are images of the same field of H520 cells treated with 2mM PA. Panel G is the 
bright field image and Panel H is the image taken with a UV emission filter. Panels I and 
J are images o f the same field of A549 cells treated with 2mM POH. Panel I is the bright 
field image and Panel J is the image taken with a UV emission filter. Panels K and L are 
the same field images of H520 cells treated with 2mM POH. Panel K is the bright field
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image and Panel L is the image taken with a UV emission filter.
Figure 6: DNA profiles following treatment with PA and POH. A540 cells (panels A, B 
and C) and H520 (panels D, E and F) cells were treated with vehicle (panels A and B) or 
1 mM PA (panels B and E) or 1 mM POH (panels C and F) for 24hrs, harvested, fixed in 
70% ethanol and stored at 4°C until analyzed.
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Table 1 : PA and MJ induced apoptosos in lung cancer cells
Treatment GO/Gl S G2/M Apoptosis
A549 Control 
A549 ImM PA 
A549 ImM 
POH
54.2 ±2.0
54.3 ± 2.5 
*67.8 ± 1.0
32.9 ±2.1 
*45.4 ±2.3 
24.7 ± 1.21
12.2 ± 0.6 
0.3 ±0.1 
7.6 ± 0.2
0.2 ±0.1 
2.9 ± 0.6 
4.4 ± 1.3
H520 Control 
H520 ImM PA 
H520 ImM 
POH
47.5 ± 0.9
50.6 ± 1.7 
48.8 ±0.9
35.5 ±2.4 
26.4 ± 1.3 
*19.6 ± 1.0
17.3 ±1.3 
*23.0 ±2.4 
*31.5 ±2.0
0.0 ± 0.0 
0.0 ± 0.0 
0.4 ± 0.3
The values are represented as Mean±SEM of two individual experiments (♦ 
p< 0.05, one tailed t-test).
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Table 2: POH and PA induced apoptosis as determined by Fluorescent Microscopy
% apoptosis
24 Hr Treatment A549 H520
0 1.2 + 0.17 2.6 ± 0.84
2mMPA ^10.2 ±2.0 *31.5 ±4.8
2mM POH *24.3 ± 1.9 * 60.7 ± 10.8
Values are MeanlSEM of two separate experiments. POH 
or PA induced significant increase in apoptotic population 
both in A549 and in H520 cells compared to the control (f 
p<0.01, and # p<0.001).
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Table 3: POH and PA increased the expression of Bclz and p21
Cell line Treatment Pg Bcb/lXlO* cells pgp21/1X10* 
cells
A549 Control 
0.5mM PA 
0.5mM POH
76.1 ±0.01
90.2 ± 0.02* 
114.7 ±0.09^
31.8 ±0.06 
50.4 ± 0.09^ 
64.1 ±0.05^
H520 Control 
0.5mM PA 
0.5mM POH
108.1 ±0.01 
127.7 ±0.0* 
114.1 ±0.04*
1.5 ±0.01
1.6 ±0.05 
2.3 ± 0.03^
Values are Mean+SEM of two separate experiments, (f p<0.01 and * p<0.05).
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CHAPTER 6
METHYL JASMONATE AND CIS-JASMONE INDUCED CELL CYCLE ARREST 
AND APOPTOSIS IN PROSTATE CANCER CELLS
6.1 Abstract
Jasmonates are stress hormones synthesized by plants in response to injury and insect 
attack. Methyl jasmonate (MJ) has been reported to inhibit cell growth in several 
established cancer cell lines. Advanced prostate cancer cells typically are hormone 
independent, resistant to apoptosis and do not respond to chemotherapeutic agents. The 
ability of MJ and cis-jasmone (CJ) to inhibit hormone independent prostate cancer cell 
lines (PC-3 and DU-145) was evaluated using both an alamarBlue assay and clonogenic 
survival. Flow cytometery and fluorescent microscopy were used to measure cell cycle 
distribution and apoptosis. Both CJ and MJ were capable of inhibiting the growth and 
inducing cell death in these cell lines. Cell cycle distribution demonstrated that CJ or MJ 
induced an S-phase arrest in PC-3 and a GO/Gl block in DU-145 cell lines. Both CJ and 
MJ induced apoptosis and mechanistic studies revealed that MJ activated TNFRI and 
caspase-3 in prostate cancer cells. The results presented in this study indicated that the 
phytochemicals CJ and MJ could be useful in the management of advanced prostate 
cancer.
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6.2 Introduction
The risk of an American male developing prostate cancer over his lifetime is one 
in six making it the most frequently diagnosed cancer in men [2]. It is the second leading 
cause of cancer-related deaths among men in the US. Prostate cancer is asymptomatic at 
the beginning with metastatic prostate cancer usually being androgen dependent. The 
primary therapy for metastatic prostate cancer is testosterone ablation and radical 
prostatectomy [3, 6]. However, in advanced stages prostate cancer becomes androgen 
insensitive, which severely limits therapeutic options. Hence there is a need to develop 
alternative treatment options for advanced androgen independent prostate cancer. Many 
different phytochemicals (both nutritive and non nutritive) have shown potential in the 
prevention/treatment of cancer including prostate cancer.
PC-3 and DU-145 are two well-studied androgen independent prostate cancer cell 
lines. These cells lines do not express p53 but do express high levels of Bcli which are 
thought to lead to the protection of cells [1, 13, 15,21]. However, these two cell lines are 
capable of undergoing apoptosis with mitochondrial damage activating the intrinsic 
pathway and overcoming the effect of the pro-survival protein Bcli [5, 17]. These cell 
lines have been used to study the effects of various phytochemicals and have proven to be 
a good model system for advanced prostate cancer.
Plants express a wide variety of compounds that have been reported to have 
protective/therapeutic effects against cancer cell lines. Jasmonates are stress hormones 
synthesized in plants in response to injury and insect attack [8]. Cis-jasmone and methyl 
jasmonate belong to the jasmonate family of compounds and have been shown to inhibit 
the growth of lung and leukemia cells in vitro and induce apoptosis [9, 19,20 ]. Though
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the mechanism of action of jasmonates is not fully known they have been reported to act 
directly on mitochondria in T lympoblastic leukemia cells [19].
The effects of CJ and MJ on prostate cancer cell lines (PC-3 and DU-145) were 
studied and found that jasmonates inhibited the proliferation of both cell lines in a dose 
and kinetic-dependent manner. Survival assays demonstrated that jasmonates inhibited 
the long-term proliferation of prostate cancer cells. They also induced a GO/Gl arrest in 
DU-145 and S-phase arrest in PC-3 cells. Investigation on TNFRI demonstrated that MJ 
increased the expression of TNFRI which signals cells to apoptosis. Studies on caspase- 
3 activity in PC-3 cell line demonstrated that jasmonates activated procaspase-3. In 
conclusion, jasmonates induced apoptosis involves activation of caspase-3 and TNFRI in 
prostate cancer cells.
6.3 Materials and methods 
Chemicals and reagents 
Ham’s F-12K and RPMI 1640 media was obtained from ATCC (Manassas, VA). 
Fetal bovine serum (FBS) and penicillin (1000 units/ml) and streptomycin (1000 pg/ml) 
(P/S) were purchased from Hyclone Laboratories (Logan, UT). Cis asmone (CJ), Methyl 
jasmonate (MJ), proteinase inhibitors, propidium iodide (PI) and ribonuclease A (RNase 
A) were obtained from Sigma Chemical Company (St. Louis, MO). Phosphate buffered 
saline (PBS, lacking Ca^^ and Mĝ "̂ ) was purchased from Invitrogen Corporation (Grand 
Island, NY). AlamarBlue was purchased from Biosource International, Inc. (Camarillo, 
CA). Sodium dodecyl sulfate, bisacrylamide, N,N,N,N*-tetramethylethylenediamine 
(TEMED) and ammonium persulfate were obtained from Bio-Rad Laboratories
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(Hercules, CA). Caspase-3 fluorimetric kit was obtained from Calbiochem (San Diego, 
CA).
Cells and cell culture 
Hormone independent human prostate adenocarcinoma cell lines (DU-145, PC3) 
were obtained from ATCC (Manassas, VA). The cells were grown in appropriate 
medium supplemented with 10% FBS and 1% P/S until the plate was 80% confluent. 
The cells were dislodged by trypsinization, counted and the appropriate number of cells 
seeded for each experiment. Stock solutions (IM) of CJ or MJ were prepared by 
dissolving each in DMSO. The indicated treatment concentrations were prepared by 
diluting the stock solution in culture medium, with occasional stirring at 37°C for 2 hr. 
For the treatment, the culture medium was replaced with treatment medium containing 
the desired concentration of each agent and incubated at 37°C in humidified, 5% CO2 
atmosphere. Cells in control plates received the medium with DMSO (<0.3% v/v). At 
termination, the effects of the agents were determined as described below.
Cvtotoxicitv assav
The cytotoxic effects of CJ or MJ on human prostate cancer cell lines were 
determined using the alamarBlue assay [12]. Reduction of the alamarBlue dye is 
proportional to the number of viable cells. Cells (5x10^) were seeded in flat bottomed 
96-well plates for 15-18 hr to undergo attachment. The culture medium was replaced 
with 100 pi of media containing varying concentrations of CJ or MJ and the cells exposed 
at 37°C in humidified 5% CO2 for 24 hr. At termination, the treatment medium in each 
well was replaced with lOOpl of fresh medium and lOpl of the alamarBlue dye. The cells 
were incubated at 37°C in humidified 5% CO2 for 4 hr. Fluorescence was measured at an
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excitation wavelength of 530 nm and emission wavelength of 590 nm using GENios 
fluorescence plate reader (PHENIX Research Products, Hayward, CA). Cell viability 
was calculated as follows:
Viability (%) = (FLT590 - Blk / FLU590 - Blk) xl 00 
FLT59o=Fluorescence of treatment group at 590nm 
FLU590- Fluorescence of untreated group at 590nm 
Blk= Blank
Colonv formation assav 
The long-term (delayed) cytotoxic effects of CJ or MJ on the prostate cancer cells 
were determined using the colony formation assay (CFA). The cells were exposed to 
different concentrations of CJ or MJ for 24 hr. The treatment medium was aspirated off 
and the cells were washed with PBS, harvested with trypsin EDTA. Cells were counted, 
plated into 60mm dishes and incubated at 37°C in humidified CO2 atmosphere for 10-14 
days. The medium was decanted and the cells were stained with crystal violet 
(0.5g/100ml in 95% ethanol). Colonies (>50 cells/colony) were counted and the 
percentage survival (%viability) was calculated relative to the control (100%) group.
Proliferation assav
The effect of CJ and MJ on the proliferation of human prostate cancer cell lines 
was assessed by proliferation assay. Cells (O.lx 10^) were plated in 60 mm dishes and 
incubated overnight at 37°C in humidified 5% CO2. Following adhesion plates were 
divided into three groups: control and treatments. Control cells received 0.1% DMSO 
and treatment groups received 2mM MJ or CJ for 9 days. Cells were harvested with 
trypsin-EDTA and the number of cells was counted using a Coulter counter. The
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procedure was followed everyday for up to 5 days and then every other day (7 and 9). 
Proliferation inhibition of PC3 and DU-145 was assessed by comparing the number of 
cells in treatment groups with control group.
Flow cvtometrv
DNA content analysis was performed to determine the effects of CJ or MJ on cell 
cycling in the cancer cell lines. Cells (1x10^) were seeded in 100 mm tissue culture 
dishes and treated as described earlier. At termination, cells were harvested, counted, 
washed with PBS, fixed in 90% ethanol and stored at 4°C. The cells were then stained 
with PI staining solution (lOOpg/ml PI, 0.1% Triton X-IOO, and Img/ml RNase A 
(DNase-free) in PBS; 1:1:1 by volume). Two thousand events were acquired on a 
FACSCalibur flow cytometer (Becton Dickinson, San Jose, CA). The percentage of the 
cells at different phases of the cell cycle was obtained using the DNA analysis software 
Modfit LT 3.0 (Verity Software House, Topsham, ME).
Fluorescence microscopv 
To detect morphological changes characteristic of apoptosis, cells were seeded in
4-well slides and exposed to 0 or 2mM CJ or MJ for 24 hr and 48 hr. At termination, 
medium was aspirated off and 500pl of the Hoechst (2pg/ml Hoechst) stain was added to 
the cells and incubated for 15 min. Morphological changes (cell blebbing, chromatin 
condensation and nuclear fragmentation) indicative of apoptosis were observed and the 
images acquired with fluorescence microscopy (Nikon Instruments Inc. Melville, NY). 
The number of cells in the bright field and Hoechst positive cells were counted and the 
percentage o f cells undergoing apoptosis was calculated as:
% apoptosis = (Number of Hoechst positive cells / Number of cells in bright field) xlOO.
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DNA gel
DNA was extracted as described in an earlier study [23]. Briefly, cells (IX  10^) 
were suspended in lOOpl of lysis buffer containing 10 mM Tris-HCl (pH 7.4), 10 mM 
EDTA, and 0.5% Triton X - 100 for 10 min at 4° C. Cells were centrifuged at 13,000 rpm 
for 5 min and RNase A (20pg/ml) was added to the supernatant and incubated for 1 hr at 
37° C. Following incubation Proteinase K was added to a concentration of 20pg/ml and 
incubated for 30 min at 50° C. DNA was precipitated with 42mM NaCl and 50% 
isoproponal overnight at -20° C. DNA pellet was obtained by centrifugation for 15 min 
at 13, 000 rpm. The DNA pellet was resuspended in 20pl TE buffer (lOmM Tris-HCl 
and ImM EDTA) and lOpl of the DNA solution was electrophoresed on a 2% agarose 
gel in TBE buffer (89 mM Tris base, 89mM boric acid and 2.6 mM EDTA). The Gel 
was stained with 1 pg/ml ethidium bromide and photographed.
Caspase-3 assav
Caspase-3 activity was measured in PC-3 cells according to the manufacturer’s 
instructions. Control and treated cells were harvested, washed, pelleted in microfuge 
tubes and stored at -20®C. For protein extraction, 60pl of the extraction buffer containing 
DTT (lOpl/lM) was added for 1x10^ cells and incubated the samples on ice for lOmin. 
The cell lysate was clarified at 500xg at 4°C for 5min. Cell lysate was used for the assay, 
caspase-3 present in the sample will cleave the fluorescent labeled (AFC) peptide 
sequence (DEVD) after aspartate residue. The reaction was monitored by a shift in 
fluorescence from blue to green.
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TNFRI expression detection 
TNFRI expression was measured by flow cytometry as described by Smolnikar et 
al []. DU-145 cells were plated and after two days cells were exposed to 0, ImM, 2mM, 
3mM MJ for 24 hr. Following exposure cells were harvested by scraping with PBS- 
EDTA (ImM), counted and Ix 10  ̂cells were incubated in 50% FBS at 4°C for 15 min. 
Cells were washed with PBS-FBS (PBS with 1% FBS added) and incubated with 
25pg/ml anti-human TNFRI antibodies (R&D Systems) at 4°C for 60 min. Subsequently 
cells were washed three times in PBS-FBS and incubated with FITC- conjugated goat 
anti-rat IgG (1:40 dilution) at 4°C for 2 hr. Cells were washed in PBS-FBS three times 
and analyzed with FACS Calibur flow cytometer. Fluorescence data was collected and 
background fluorescence was determined using unstained cells.
6.4 Statistical analyses 
The results were represented as Mean ± SEM of triplicate analyses accompanied 
by number of independent experiments. Statistical analysis was performed using t-test 
(Graphpad Software INC., CA, USA and Excel). Differences at p<0.05 or better were 
considered statistically signiflcant.
6.5 Results
MJ and CJ inhibited the growth of prostate cancer cells 
Both MJ and CJ inhibited the proliferation of prostate cancer cells in a dose and 
kinetic dependent manner (Figure 1 A, IB, 1C and ID). The concentrations that inhibited 
cell proliferation of PC-3 by 50% ( I C 5 0 )  at 24 hr and 48 hr were 2.75mM and 2.37mM for
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MJ (Figure lA), and 3.0mM for CJ at 48 hr (Figure IB). The IC50 values of DU-145 for 
MJ are 2 .ImM and 1.8mM at 24 hr and 48 hr (Figure 1C). The CJ IC50 values were
2. ImM and 2.2mM respectively (Figure ID). The effects of exposure to MJ or CJ for 24 
hr were also evaluated using a colony formation assay (Figure 2). Both MJ and CJ 
inhibited the long-term proliferation of prostate cancer cells in vitro. The IC50 values for 
MJ were l.OmM (PC-3), 1.75mM (DU-145) and for CJ are 1.25mM (PC-3) and 1.5mM 
(DU-145). We also investigated the proliferation of cells over 9-day period and we 
observed that 2m MJ and 2mM CJ inhibited the 95% of growth of PC-3 and DU-145 
cells (Figure 3A and 3B) while control cells continued to grow.
MJ and CJ induced cell cvcle arrest and apoptosis in PC-3 and DU-145 cells
Both CJ and MJ induced cell cycle arrest in prostate cancer cells at 24 hr and 48 
hr. CJ and MJ showed S phase arrest in PC-3 cells both at 24 hr and 48 hr (Figure 4). In 
DU-145 cells ImM, 2mM and 3mM MJ or CJ caused a prominent block at GO/Gl phase 
and 2mM concentration is more effective than the others (Figure 5). We also observed 
increased apoptotic population in PC-3 and DU-145 cells with increasing concentration 
of the jasmonates both at 24 hr and 48 hr.
To confirm apoptosis, cells were stained with Hoechst and the images were 
acquired with fluorescence microscopy. Percent apoptosis was calculated from Hoechst 
positive cells compared to control cells. CJ induced apoptosis in both PC-3 and DU-145 
cells. CJ at 24 hr showed 4.79 % apoptosis in PC-3 and 6.67% in DU-145 cells (Figure 
6). While MJ treated cells displayed an increase in apoptosis at 48 hr, it was not a 
statistically significant increase (Figure 6). DNA fragmentation, a sign of apoptosis was 
observed with CJ and MJ (Figure 7). Both of these agents caused a smear at 3 mM
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(Figure 7). All the apoptotic assays confirmed that both CJ and MJ induce apoptosis in 
prostate cancer cells.
Jasmonates induced apoptosis involves activation of caspase-3 and expression of TNFRI 
CJ and MJ activated caspase-3 in PC-3 and DU-145 cells. Caspase-3 (DEVDase 
activity) was activated by 3 hr, which was the earliest time point measured (Figure 8). 
Caspase-3 stayed elevated for at least 24 hrs which was the latest time point measured 
(Figure 8). In DU-145 cells MJ increased TNFRI expression and is dose dependent. At 
all three concentrations of MJ (1, 2, 3) there was an increase in TNFRI activity compared 
to the control the highest increase being at 3mM concentration (Figure 9).
6.6 Discussion and conclusion 
Jasmonates are novel anticancer agents that have been reported to inhibit the 
growth and induce cell death in prostate, melanoma, lung, lymphoma and leukemia cells 
[9, 16, 19, 20]. The results presented here as well as previous studies demonstrated that 
the jasmonates inhibited the proliferation of hormone independent prostate cancer cells 
(PC-3 and DU-145) (Figure 1). Survival assays and proliferation assays showed that both 
CJ and MJ inhibit the long-term proliferation (Figures 2 and 3). Cell cycle distribution 
demonstrated that CJ and MJ induced S-phase arrest in PC-3 and GO/Gl block in DU-145 
cell lines (Figures 4 and 5). Apoptotic studies using flow cytometry and fluorescent 
microscopy detected an increased amount of apoptotic cells in treatment groups 
compared to control (Figures 4, 5 and 6). DNA fragmentation, an indication of apoptosis, 
was also observed in PC-3 cells following MJ exposure (Figure 7). CJ and MJ induced 
apoptosis in similar signaling pathways by activating caspase-3 in PC-3 cells (Figure 8).
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To the best of our knowledge this is the first report to demonstrate that CJ and MJ 
inhibited the growth of hormone independent human prostate carcinoma PC-3 and DU- 
145 cells. In prostate cancer cell lines it was found that CJ and MJ inhibited growth is a 
result of cell cycle arrest and apoptosis. Cell signaling studies demonstrated that increase 
in TNFRI expression and caspase-3 activation result in cell death..
Jasmonates belong to the family of oxygenated fatty acid derivatives, oxylipins, 
which are produced via the oxidative metabolism of polyunsaturated fatty acids, usually 
linolenic acid (Cigj) [10]. The jasmonates have a variety of effects in both plant and 
animal cells. To date, three separate mechanisms have been proposed to explain the 
anticancer effects of jasmonates. These include: (i) the ability of MJ to open the 
mitochondrial permeability transition pore complex releasing cytochrome c and inducing 
apoptosis [19]; (ii) the ability of MJ to induce the re-differentiation of leukemia cells 
[14]; and finally (iii) the ability of MJ to induce the expression of reactive oxygen species 
[16]. In addition to inhibiting the proliferation of cancer cell lines while not inhibiting 
the growth of normal cell lines, jasmonates can bypass drug resistance induced be either 
p53 mutation or by expression of P-gp [10]. In our study we demonstrated that MJ 
increases death receptor protein TNFRI expression indicating extrinsic apoptotic 
signaling in cancer cells (Figure 9). TNFRI expression was also observed in lung and 
breast cancer cells (Manuscripts submitted). These observations clearly indicate that the 
jasmonates hold potential as effective phytochemicals in the prevention/treatment of 
prostate cancer.
The results presented in this study indicated that jasmonates have the potential to 
be chemotherapeutic agents in the treatment of prostate cancer. CJ and MJ induced cell
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cycle arrest and apoptosis in prostate cancer cells, an observation consistent with earlier 
reports using other cancer cell lines [9, 16, 19, 20]. Apoptosis is preferred as a targeted 
therapy for various cancers including prostate cancer since it does not induce an 
inflammatory response [11]. Hormone independent prostate cancer cells typically become 
resistant to apoptosis and do not respond to chemotherapeutic agents. This study 
demonstrated that both CJ and MJ can induce apoptosis in hormone independent prostate 
cancer cells and hence could be useful as chemotherapeutic agents in the management of 
advanced prostate cancer [7,18].
The two prostate cancer cell lines studied (PC-3 and DU-145) are deficient in 
functional p53 expression and hence are expected to display similar effects on cell cycle 
and apoptosis. However, studies using a variety of phytochemicals indicated that these 
two cell lines display differences in responses to these potential anticancer compounds. 
In PC-3 cells previous studies reported that resveratrol (a polyphenol found in grapes) 
showed GO/Gl arrest at higher concentration (50pM) and transient increase in S-phase at 
lower concentrations (10 pM) [4]. Decursin (a coumarin compound) also induced arrest 
at GO/Gl, S and G2/M phases depending upon concentration and time in PC-3 and 
GO/Gl arrest in DU-145 cells [22]. This study found that in PC-3 cells CJ and MJ caused
S-phase arrest while in DU-145 a GO/Gl arrest was observed. These arrests increased 
with both concentration of jasmonate and time of exposure (Figures 4 and 5). Both PC-3 
and DU-145 displayed decreased proliferation in the presence of CJ and MJ but the 
specific site of cell cycle arrest differed between these two hormone independent prostate 
cancer cell lines. The results presented here along with previous studies indicate that 
although PC-3 and DU-145 cell lines both lack a functional p53 gene product, their
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responses to phytochemicals are an indication that proteins other than p53 play a crucial 
role in the response to these agents.
In conclusion, the results from this study demonstrate anticancer effects of 
jasmonates with mechanistic rationale (cell cycle arrest, apoptosis and TNFRI 
expression) against advanced (hormone independent) prostate cancer cells. Further 
apoptotic pathway studies, in vivo studies and clinical trials will provide the information 
necessary to develop jasmonates as novel agents for the prevention and treatment against 
prostate cancer.
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6.9 Figure legends
Figure 1: Cytotoxicity of CJ and MJ was determined after 24 and 48 hr exposure in 
human prostate cancer cells (PC-3 and Du-145). Panel A: PC-3 cells were exposed to MJ 
and cell viability was assessed by mitochondrial dehydrogenase assay using alamarBlue 
dye as described in methods section. Panel B: PC-3 cells were exposed to CJ. Panel C: 
DU-145 cells were exposed to MJ and Panel D: DU-145 cells were treated with CJ. Cell 
viability was calculated as a percentage of untreated cells (100%). Values were 
Mean±SEM (n=6); results are representative of three independent experiments. At 
1.5mM and higher concentrations of CJ or MJ, there was a significant ($ p<0.0001, one­
tailed t-test) decrease in the viability of PC-3 and DU-145 cells compared to the control. 
Figure 2: CJ and MJ inhibited the long-term proliferation of PC-3 and DU-145 cells. 
Panel A: PC-3 cells were exposed to CJ or MJ for 24 hr. Panel B: DU-145 cells were 
exposed to CJ or MJ for 24 hr. The drugs were washed off and the effects on long-term 
cell proliferation were determined as explained in methods section. Values are 
Mean±SEM; results are representative of two separate experiments of triplicate analyses. 
CJ and MJ significantly inhibited the long-term proliferation of PC-3 cells ($ p<0.0001, 
one-tailed t-test) at all concentrations studied. At 1.0 mM and higher concentrations of CJ
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significant decrease in survival of DU-145 cells was observed ( t p<0.001, one-tailed t- 
test) whereas MJ showed significant decrease in survival at 1.5 mM and higher 
concentrations.
Figure 3: CJ and MJ inhibited the proliferation of prostate cancer cells. Panel A: PC-3 
cells were exposed to 2mM CJ or 2mM MJ and number of cells was counted everyday 
for 5 days and every alternate day after that until 9 days. Panel B; DU-145 cells were 
exposed to 2mM CJ or 2mM MJ and cell number was determined every day for 5 days 
and every alternate day after 5 days. Values are Mean+SEM and representative of 
triplicate analyses from two different experiments. Both CJ and MJ showed significant 
growth inhibition of PC-3 (J p<0.0001) and DU-145 ( |  p<0.0001) cells.
Figure 4: CJ and MJ induced cell cycle arrest in PC-3 cells. Cells (1.0x10^) were exposed 
to 0 ,1 ,2  and 3mM CJ or MJ for 24 hr (Panels A and C) and 48 hr (Panels B and D). Cell 
cycle distribution was determined with FACSCalibur flow cytometry as described in the 
materials and methods. Values are Mean+SEM of triplicate analyses. Data are 
representative of two different experiments. Statistical analysis was performed by two- 
tailed t-test and a significant S phase block was observed in PC-3 cells at 24hr (* p<0.05) 
(Panel A and C) and 48 hr ( # p<0.01) (Panels B-D). A significant increase in apoptosis 
was observed with 3 mM MJ or CJ at both 24 and 48 hrs (Panels A-D).
Figure 5: CJ and MJ induced cell cycle arrest in DU-145 cells. Cells (1.0x10^) were 
exposed to 0, 1,2 and 3mM CJ or MJ for 24 hr (Panels A and C) and 48 hr (Panels B and 
D). Cell cycle distribution was determined with FACSCalibur flow cytometry as 
described in the materials and methods. Values are Mean+SEM of triplicate analyses. 
Data are representative of two different experiments. Statistical analysis was performed
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by two-tailed t-test and significant GO/Gl block was observed at 24 hr ( f  p<0.001) and 
48 hr (# p<0.01) in DU-145 (Panels A-D). A significant increase in apoptosis was 
observed with 3 mM MJ or CJ at both 24 and 48 hrs (Panels A-D).
Figure 6: CJ and MJ induced apoptosis in PC-3 and DU-145 cell lines. Panel A: PC-3 
and DU-145 cells were exposed to 2 mM CJ and 2 mM MJ for 24 hr. Panel B: PC-3 and 
DU-145 cells were exposed to 2mM MJ for 48 hr. The percentage of Hoechst positive 
cells with morphological changes for apoptosis was calculated as explained in methods. 
The results are representative of two separate experiments done in triplicates and values 
are represented as Mean+SEM. At 24 hr CJ induced significant increase in apoptosis in 
PC-3 (Panel A, * p<0.05, one tailed t-test) and DU-145 (Panel A, # p<0.01, one tailed t- 
test) cells. At 48 hr 2mM MJ induced apoptosis is not statistically significant (Panel B). 
Figure 7: Representative DNA gel picture of PC-3 cells treated with CJ and MJ. (1) DNA 
ladder (2) Control cells, (3) ImM CJ, (4) 2mM CJ, (5) 3mM CJ (6) ImM MJ (7) 2mM 
MJ (8) 3mM MJ (9) 4 hr sodium deoxycholate (10) 8 hr sodium deoxycholate. Cells 
treated with sodium deoxycholate were used as positive controls. DNA smear was 
observed with 3mM CJ or MJ and with sodium deoxycholate.
Figure 8: Caspase-3 activity was measured with fiuoremetric kit as explained in methods. 
Both CJ (Panel A) and MJ (Panel B) induced activation of caspase-3 from the earliest (3 
hr) to the latest time point (24 hr) measured. At all time points the samples were 
incubated with caspase-3 substrate.
Figure 9: Tumomecrosis factor receptor l(TNFRl) activity was measured by flow as 
explained in methods. Panel A: DU-145 cells treated with DMSO for 24 hr. Panel B: DU- 
145 cells were exposed to ImM MJ for 24 hr. Panel C: DU-145 cells treated with 2mM
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MJ for 24 hr. Panel D: DU-145 cells treated with 3mM MJ for 24 hr. Cells treated with 
MJ showed significant increase in TNFRl expression which was indicated by higher 
fluorescence intensity and a shift in histogram peak compared to the control.
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CHAPTER 7
METHYL JASMONATE INDUCES APOPTOSIS VIA TUMOR NECROSIS FACTOR 
RECEPTOR 1 IN HUMAN BREAST CANCER CELL LINES
7.1 Abstract
In recent years studies with plant compounds have shown both chemotherapeutic and 
chemopreventive properties on cancer cells. The current study with plant stress 
hormones (jasmonates) revealed growth inhibitory effects on breast cancer cells. Both 
assays, mitochondrial dehydrogenase and survival demonstrated that CJ and MJ inhibited 
the growth of MDA-MB-435 and MCF-7 cell lines. Cell cycle analysis showed GO/Gl 
and S- phase arrest in breast cancer cells. Apoptotic assays demonstrated that jasmonates 
induced apoptosis in MDA-MB-435 and MCF-7 cells. Flow cytometry analysis of 
TNFRl expression exhibited activation of TNFRl and cell signaling studies elucidated 
that caspase-8, caspase-2, MAPK and caspase-3 were activated. Hence MJ could have 
potential applications for chemotherapeutic purposes.
7.2 Introduction
Breast cancer is the second leading cause of cancer deaths among women in the 
US [1]. An estimated 40,910 breast cancer deaths and 180, 510 new cases are anticipated 
among women in 2007 [1]. Chemotherapy, radiation, surgery and immunotherapy are 
among the current treatment options for breast cancer. Chemotherapy using synthetic
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compounds usually shows severe side effects. In recent years studies have shown that 
plant compounds have chemotherapeutic and pharmacological activities against wide 
type of cancers and could be alternative chemotherapeutic agents with low toxicity [2-7].
Jasmonates are plant stress hormones synthesized in plants in response to injury, 
insect attack and wounding [8]. Cis-jasmone (CJ) and methyljasmonate (MJ) belong to 
the jasmonte family of compounds. Jasmonates have been reported to inhibit the growth 
of leukemia cells, lung and prostate cancer cells [9, 10]. Jasmonates have been shown to 
act directly on mitochondria to release cytochrome c for apoptosis induction [11]. 
Methyl jasmonate induced apoptosis in A549 cells activated bax/bclx/s, and caspase- 
3[12].
Apoptosis is a cellular suicide mechanism that occurs by extrinsic or intrinsic 
mechanisms [13]. The extrinsic apoptotic pathway involves a superfamily of death 
receptor ligands such as tumor necrosis factor alpha (TNF- a), TNF-related apoptosis 
inducing ligand (TRAIL) and FAS (CD95/APO-1) [14]. In breast cancer cells TNF- 
a  plays an important role in cellular responses, including inflammation and apoptosis 
[15-17]. TN F-a exerts its biological functionality by binding to two membrane 
receptors, tumor necrosis factor receptor 1 (TNF-Rl) and tumor necrosis factor receptor 2 
(TNF-R2) [16]. The major TNF signaling occurs through TNF-Rl where as TNF-R2 can 
only be activated by membrane bound TNF but not by soluble TNF [16]. Activation of 
these receptors, recruit F ADD (Fas associated death domain) and TRADD (TNF 
receptor-associated death domain) leading to activation of caspase-8, mitogen activated 
protein kinase (MAPK) and ultimately cell death [16]. Several studies have reported that
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both caspase-8 and MAPK can either directly activate caspase-3 via bid or activate 
intrinsic apoptotic pathway [16,18].
MAPK pathway is part of extrinsic apoptotic mechanism, plays important role by 
regulating number of downstream molecules, kinases, scaffold proteins and the balance 
between these molecuels exerts cellular responses including cell proliferation, cell cycle 
arrest, migration, differentiation and apoptosis. Takenaka et al. found that the p38- 
MAPK pathway was activated during mitotic arrest in mammalian cultured cells [19-27]. 
Bulavin et al. also reported that p38a-MAPK was activated in response to UV radiation 
and induced G2/M cell cycle arrest by decreasing CDC2 activity [22]. CDC2 can 
phosphorylate BAD and induce neuronal apoptosis [23]. ERKl and ERK2 kinases have 
reported to be activated by phoshorylation in réponse to stress and induced cell death [24- 
27]. MAPK signals intrinsic apoptotic proteins and ultimately causing cell death.
The intrinsic apoptotic pathway can occur either by caspase-8/caspase-2 mediated 
bid cleavage or by direct stress to mitochondria. Decrease in mitochondrial membrane 
potential leads to cytochrome c release [28-30]. Cytochrome c can form an apoptosome 
complex with apaf-1 (apoptotic protease activating factor-1) and procaspase-9. The 
apoptosome complex then activates caspase-3, caspase-6 and caspase-7 resulting cell 
death [31].
The effects of CJ and MJ on breast cancer cells were studied using cytotoxicity, 
proliferation, DNA content analyses, apoptotic assays, ELISA and western blotting 
techniques. This study showed that CJ and MJ inhibited the growth of breast cancer 
cells. Cell cycle analysis and apoptotic assays have shown that CJ or MJ induced cell 
cycle arrest and apoptosis in breast cancer cell lines. Studies on membrane fluidity
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demonstrated that MJ decreases membrane fluidity which initiates cell signaling. It was 
found that MJ increased TNFRl expression and activated extrinsic apoptotic proteins, 
caspase-8, caspase-2 and MAPK. Intrinsic apoptotic mechanism studies demonstrated 
that MJ decreased mitochondrial membrane potential and activated caspase-3 in breast 
cancer cells. This study indicates that MJ induced apoptosis is associated with a decrease 
in membrane fluidity and intracellular signaling via TNFRl, MAPK, caspases-8, caspase- 
2 and caspase-3.
7.3 Materials and methods 
Chemicals and reagents 
Cell culture media (MEM), fetal bovine serum (FBS) and penicillin (1000 units/ml) and 
streptomycin (1000 pg/ml) (P/S) were purchased from GIBCO (Grand Island, NY). Cis- 
jasmone (CJ), methyl j asmonate (MJ), protease inhibitors, propidium iodide (PI), 
deoxycholic acid (DCA), 1, 6-biphenyl-1, 2, 6-trihydrazine (DPH) and ribonuclease were 
obtained from Sigma Chemical Company (St. Louis, MO). Phosphate buffered saline 
(PBS, lacking Ca^^ and Mg^^) was purchased from Invitrogen Corporation (Grand Island, 
NY). Sodium dodecylsulfate, bisacrylamide, N, N, N, N  ̂-  tetra-methylethylenediamine 
(TEMED) and ammonium persulfate were obtained from Bio-Rad Laboratories 
(Hercules, CA). Primary antibody to caspase-3 was obtained from Pharmingen (Franklin 
Lakes, NJ) and caspase-8 was from EMD Biosciences (San Diego, CA). Enzyme 
conjugated horse raddish peroxidase (HRP) secondary antibody, standards were obtained 
from Santra Cruz Biotechnology, Inc. (Santa Cruz, CA). ECL+ western blotting detection
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system was from Amersham Biosciences (Piscataway, NJ). All other reagents and 
chemicals were of the purest grade and were obtained from reputable vendors.
Cell culture
Breast cancer cell lines (MDA-MB-435, and MCF7) were obtained from ATCC. All 
cultures were maintained in MEM supplemented with 10% FBS, 1% of pencillin and 
streptomycin (lOOOunits/ml) and HEPES buffer. All the cultures were maintained at 
37°C in humidified 5% CO2 atmoshphere. During exposure to the compounds medium 
was replaced with treatment medium and control cells received medium with DMSO 
(G.1%-0.3%).
Cvtotoxicitv assav
Cells (5000) were plated in 96-well plate and incubated overnight to adhere to the plate. 
Cells were exposed to varying concentrations of CJ or MJ for 24hr. At termination 
medium was replaced with lOOpl of fresh medium, lOpl of alamarBlue was added and 
incubated for 4 hr. After 4 hr fluorescence was measured at 530 nm of excitation and 590 
nm of emission wavelengths with Genios fluorescence plate reader (PHENIX Research 
Products, Hayward, CA). Cell viability was calculated as percentage of control (100%).
Colonv formation assav 
The long-term (delayed) cytotoxic effects of agents on the breast cancer cells were 
determined using the colony formation assay (CFA). The cells were exposed to 0.5, 1.0 
and 2.0 mM concentrations of compounds for 24 hr. The treatment medium was poured 
off and the cells were washed with IX PBS, harvested with trypsin EDTA, counted and 
replated into 60mm dishes. Cells were incubated in humidified CO2 atmosphere at 37°C 
for 11 days. The medium was decanted and cells were stained with crystal violet
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(0.5g/100ml in 95% ethanol). Colonies (>50 cells/colony) were counted and the 
percentage survival (%viability) was calculated relative to the control (100%) group.
Cell cvcle analvsis bv propidium iodide 
Cells (0.25x10^) were plated in 100mm tissue culture plates, incubated overnight to 
adhere to the plate. Cells were exposed to 0.5mM and 3mM CJ or MJ for 24hr and 
washed with IX PBS. Fresh complete medium was added and incubated for 24hr. Cells 
were harvested with trypsin EDTA, washed with PBS, counted, fixed with lOOpl o f PBS 
and 900pl of absolute ethanol and stored at 4°C prior to DNA content analyses. Samples 
were stained with DNA staining solution containing 150pg/ml of PI, 0.1% Triton x-100 
and 1 mg/ml of RNase-A (DNase fi*ee) (1:1:1 by volume) and incubated in dark for an 
hour. Acquisition of the data was carried out with FACSCalibur flow cytometer (Becton 
Dickinson, Sanjose, CA) and analyzed with ModfitLT 3.0 software (Verity Software 
House, Topsham, ME).
Detection of apoptosis bv Hoechst and DNA fragmentation 
Cells (0.01x10^) were plated in 4-well slides and incubated for 24hr before 
treatment. Cells were exposed to 3.0mM CJ or MJ for 24hr, at termination medium was 
aspirated off, stained with Hoechst (2pg/ml Hoechst) for 15min. Morphological changes 
indicative of apoptosis were observed and the images acquired with fluorescence 
microscopy (Nikon Instruments Inc. Melville, NY). The number of cells in the bright 
field and Hoechst stained cells were counted and percentage of apoptotic cells was 
calculated as:
% apoptosis = (Number of Hoechst positive cells/Number of cells in bright field) x 100
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Cells (1x10^) were seeded in 75mm tissue culture flask and treated with 1, 2 and 
3mM MJ for 24 hr. Cells treated with DCA for 4hr and 8hr were positive controls. At 
termination cells were harvested with trypsin EDTA, washed with IX PBS and DNA was 
extracted as described in an earlier study [38]. Briefly, cells (IX  10®) were suspended in 
lOOpl of lysis buffer containing 10 mM Tris-HCl (pH 7.4), 10 mM EDTA, and 0.5% 
Triton X- 100 for 10 min at 4° C. Cells were centrifuged at 13,000 rpm for 5 min and 
RNase A (20pg/ml) was added to the supernatant and incubated for 1 hr at 37° C. 
Following incubation Proteinase K was added to a concentration of 20pg/ml and 
incubated for 30 min at 50° C. DNA was precipitated with 42mM NaCl and 50% 
isoproponal overnight at -20° C. DNA pellet was obtained by centrifugation for 15 min 
at 13, 000 rpm. The DNA pellet was resuspended in 20pl TE buffer (lOmM Tris-HCl 
and ImM EDTA) and lOpl of the DNA solution was electrophoresed on a 2% agarose 
gel in TBE buffer (89 mM Tris base, 89mM boric acid and 2.6 mM EDTA). The Gel 
was stained with 1 pg/ml ethidium bromide and photographed.
Membrane fluiditv studies
Cells (0.5 X 10®) were plated in 75mm tissue culture flask and incubated for two days.
Cells were exposed to 3mM MJ, lOuM cholesterol, 500uM DCA for 4 hr. At termination
cells were harvested, washed with PBS, fluorescence dye DPH (2pM) was added and
polarization was measured with LS 55 Luminescence Spectrometer (Perkin Elmer) P
value was calculated by using the following formula:
Iw  - IGF X Ivhl GF = Ihv/Ihh 
P = Iw  + (GF X Ivh)
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TNFRl expression detection 
TNFRl expression was measured by flow cytometry as described by Smolnikar et 
al. MDA-MB-435 and MCF-7 cells were plated and after two days cells were exposed to 
0, ImM, 2mM, 3mM MJ for 24 hr. Following exposure cells were harvested with PBS- 
EDTA (ImM), counted and 1x10® cells were washed in 50% FBS at 4°C for 15 min. 
Cells were washed with PBS-FBS (PBS with 1% FBS added) and incubated with 
25pg/ml anti-human TNFRl antibodies (R&D Systems) at 4“C for 60 min. Subsequently 
cells were washed three times in PBS-FBS and incubated with FITC- conjugated goat 
anti-rat IgG (1:40 dilution) at at 4°C for 2 hr. Cells were washed in PBS-FBS three times 
and analyzed with FACS Calibur flow cytometer. Fluorescence data was collected and 
background fluorescence was determined using unstained cells.
MAPK assav bv ELISA 
p38 and ERKl/2 activity was determined by an ELISA assay kit (Super array, 
Frederick MD). Cells (1.5 X 10'*) were plated in a 96-well plate and incubated overnight 
in humidified 5% CO2 atmosphere at 37°C. The following day, cells were serum starved 
for 18-24 hr, exposed to MJ and assayed. Briefly, adherent cells were fixed to the plate, 
washed, blocked and incubated with a primary antibody followed by a secondary 
antibody. Then developing solution was added and the samples were allowed to incubate 
for 10 min at room temp, before the stop solution was added. Absorbance was measured 
at 450 nm. Relative phosphorylation was normalized to cell number according to 
manufacturer’s instructions.
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Metabolism of MJ in arachidonic acid pathways 
Cells (0.5 X 10"*) were plated in 96-well plate and incubated overnight. Cells 
were exposed to lipoxygenase, cycloxygenase and p450 inhibitors and IC50 MJ for 24 hr. 
At termination medium was aspirated off, fresh medium, alamarBlue was added and 
incubated for 4hr. Fluorescence measurements were taken with Genios plate reader 
(PHENIX Research Products, Hayward, CA). Cell viability was calculated as percentage 
of control (100%).
Caspase-8. 2. 3 and membrane potential studies 
The expression of caspase-3, and caspase-8 was determined using western blot 
analysis. Control or treated (1.0x10®) cells were harvested with trypsin EDTA, pelleted 
into microfuge tubes at 1000 rpm for 10 min, stored in -80°C and protein extraction was 
carried out according to the manfacturer’s instructions (Biosource Intl. Inc., Camarillo, 
CA). The cell pellet was thawed on ice for 2hr prior to protein extraction. lOOpl of 
extraction buffer containing protienase inhibitor (250pl/5ml) and PMSF (ImM) was 
added to 1x10® cells, with occasional mixing for every 10 min about 30 min. The cell 
lysate was centrifuged at 13,000 rpm at 4°C for 10 min; supernatant was collected, 
aliquoted into tubes and stored at -80°C. Total protein concentration was determined 
using BCA protein assay kit (Pierce, Rockford, IE). Equal amount of protein was loaded, 
subjected to SDS-PAGE and transferred to PVDF membrane. The membrane was 
blocked for 1 hr at room temperature with blocking solution (10% nonfat dry milk 
solution + 0.05% tween 20%) and washed twice with IX western wash (12.4 mM trizma,
37.4 mM NaCl, 0.5% TritonX-100, pH 7.4),. Then blot was incubated with primary 
antibodies (Ipg/ml) to caspase-3 or caspase-8 for Ihr at room temperature. Followed by
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washing three times with IX western wash primary antibody was detected with 1:1000 
diluted horse raddish peroxidase (HRP) or fluorescence secondary antibodies. HRP 
antibody signal was developed with ECL+ detection kit (Amersham Biosciences, 
Piscataway, NJ) and visualized with TYPHOON 9410 (Amersham Biosciences, 
Piscataway, NJ).
Caspase-3 and caspse-2 activity was measured by flow cytometry as described in 
manufacturers protocol (Biovision, CA). Briefly cells were exposed to 3mM MJ for 4 
and 24 hr, harvested, counted and washed with PBS. Caspase-3 and caspase-2 substrates 
were added and washed with wash buffer (provided by the manufacturer) and activity 
was measured by flow cytometry.
Mitochondrial membrane potential was measured as described in manufacturer’s 
protocol (Cell technology, CA). MDA-MB-435 and MCF-7 cells were plated and 
incubated overnight. Cells were exposed to 0, IC50MJ (concentration that inhibits 
growth of 50% of cells), 3mM MJ for 24 hr. At termination cells were harvested, 
counted, washed with PBS, 0.5 X 10® cells were stained with JC-1 reagent and incubated 
for 15 min at 37° C. Cells were washed twice with assay buffer (provided by 
manufacturer) and membrane potential was measured by flow cytometry. Intact 
mitochondria will have red color fluorescence and the dye appears green in the cytosol.
7.4 Statistical analyses 
The results were presented as Mean ± SEM of replicate analyses accompanied by number 
of independent experiments. Statistical analyses were performed using one or two tailed
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t-test (Graphpad Software Inc., San Diego CA and Microsoft Excel). Differences at 
p<0.05 or better were considered statistically significant.
7.5 Results
CJ and MJ inhibited the growth of breast cancer cells 
Proliferation inhibition of breast cancer cells was determined by cytotoxicity 
assay using almarBlue dye. Plant compounds CJ and MJ inhibited the growth of breast 
cancer cell lines in-vitro. The concentration of CJ at which 50% of MDA-MB-435 cells 
growth (IC50) was inhibited after 24 hr treatment was 1.7 mM, 2.5 mM for MCF-7 cells 
(Figure lA). The IC50 of MJ for MDA-MB-435 was 1.9 mM and 2.0 mM for MCF-7 
cells (Figure IB). CJ and MJ were not cytotoxic to CDC-1070-SK and MCF-lOA normal 
cells (Figure 1C)
Inhibition of long-term proliferation of breast cancer cells by CJ or MJ was 
evaluated by clonogenic survival assay. The concentration of CJ at which 50% of long­
term proliferation of MDA-MB-435 and MCF-7 cells was inhibited (IC50) after 24 hr 
treatment was 1.2mM (Figure 2A). The IC50 of MJ for MDA-MB-435 was 1.2mM and 
1.45mM for MCF-7 respectively (Figure 2B). A time course with MDA-MB-435 and 
MCF-7 cells at 3mM CJ or MJ showed time dependent decrease in survival (Figure 2C 
and 2D). At 2 hr, CJ inhibited the long-term proliferation of 70% of MDA-MB-435,60% 
of MCF-7 cells while MJ inhibited the long-term proliferation of 70% of both MDA-MB- 
435 and MCF-7 cells in-vitro (Figure 2C and 2D).
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Cell cvcle analvsis
To investigate the cell cycle arrest DNA content analyses was carried out by 
propidium iodide staining using flow cytometry. Representative histograms of MDA- 
MB-435 and MCF-7 cells treated with CJ and MJ showed an increase in apoptotic peak 
compared to the control (Figure 3A and 3B). CJ and MJ induced cell cycle arrest and 
apoptosis in breast cancer cell lines (Figure 3). CJ and MJ induced GO/Gl arrest in 
MDA-MB-435 and in MCF-7 cell lines (Figure 3C and 3D). At 3mM MJ MDA-MB-435 
cells showed a block at S-phase while 3mM CJ showed an S-phase block in MCF-7 cells 
(Figure 3C and 3D). An increase in sub-diploid population was observed with 3mM MJ 
in both MDA-MB-435 and MCF-7 cells (Figure 3C and 3D).
Apoptotic assav
Apoptotic studies have demonstrated that CJ or MJ induced apoptosis in breast 
cancer cells (Figure 3). To confirm apoptosis induction cells were stained with Floechst, 
images were acquired with fluorescence microscopy and percent of apoptotic cells were 
calculated as explained in methods (Table 1). Cells treated with CJ or MJ showed 
morphological changes of apoptosis (cell shape had changed to elongated from oval) and 
increased significant amount of apoptosis in breast cancer cells (Figure 4 A, 4B, 4C and 
4D). MDA-MB-435 and MCF-7 cells showed 35.0% and 37.2% apoptosis with MJ. CJ 
induced 6.6% (MDA-MB-435) and 43.5% (MCF-7) apoptosis respectively (Table 1).
Further studies on DNA laddering with MJ after 24 hr treatment showed DNA 
smear in MDA-MB-435 cells but not in MCF-7 cells (Figure 4F). DNA smear was 
observed only with 3mM MJ but not with! or 2mM MJ (Figure 4F). DNA laddering was
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observed in MDA-MB-435 cells treated with DCA for 4 and 8 hr which were positive 
controls (Figure 4F).
Membrane fluiditv
MJ is a hydrophobic molecule and expected to decrease the membrane fluidity of 
cells. Cells treated with cholesterol and DCA were positive controls. MDA-MB-435 and 
MCF-7 cells treated with 3mM MJ, DCA and cholesterol for 4hr showed an increase in P 
value compared to the control (Table 2). An increase in P value indicates a decrease in 
the membrane fluidity in both the cell lines (Table 2).
Cellular signaling
Studies on death receptor elucidated that TNFRl expression was increased and 
initiated death signals in breast cancer cells. TNFRl increased expression was dose 
dependent in both MD-MB-435 and MCF-7 cells (Figure 5A-5H). To confirm cell 
signaling caspase-8, caspase-2 and MAPK activity was measured. Increased p38 and 
ERKl/2 activity was observed after exposure of cells to MJ. p38 was activated starting at 
2.0hr and ERKl/2 activity was observed after l.Ohr treatment with 3mM MJ in MDA- 
MB-435 but not in MCF-7 cell line (Figure 5H and 51, MCF-7 data not shown). Caspase- 
8 was activated starting at 2hr in MDA-MB-435 cells treated with 3mM MJ but not in 
MCF-7 cells (Figure 6A). Procaspase-8 was cleaved and activated until 8 hr in MDA- 
MB-435 cells (Figure 6A). In MCF-7 cells caspase-2 was activated at 4 hr (Figure 6B, 
6C and 6D-westem will be carried out to confirm). To elucidate the involvement of 
mitochondria in response to MJ induced apoptosis mitochondrial membrane potential and
i
caspase-3 activity was measured. MJ treated cells showed decreased membrane potential 
and procaspase-3 activity compared to the control except in caspase-3 mutant cell line
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MCF-7 (Figure 6E, 6F and 6G). Flow cytometry analysis demonstrated that caspase-3 
activity was increased in MDA-MB-435 cell line without any change in MCF-7 cells 
(Figure 6F).
MJ metabolism through arachidonic acid pathways 
MJ resembles arachidonic acid in its structure and hence MJ is expected to 
metabolize through arachidonate pathways. MDA-MB-435 cells were treated 
simultaneous with lipoxygenase, cycloxygenase and p450 inhibitors and IC50MJ 
(survival). If MJ metabolizes through these pathways, inhibitor treatment would increase 
the viability of cells. There was no increase in viability of cells treated simultaneously 
with inhibitors and MJ. MJ does not metabolize through arachidonate pathways (data not 
shown).
7.6 Discussion and conclusion 
Breast cancer is the second leading cause of cancer related deaths among women 
in the US. Alternative strategies are required to combat the breast cancer deaths. 
Jasmonates are plant compounds, which have shown growth inhibitory and apoptotic 
activities on lung and prostate cancer cells. How ever the chemotherapeutic effects of 
these compounds have not been investigated in breast cancer cells.
Results presented here demonstrated that jasmonates inhibit growth, induce cell 
cycle arrest and apoptosis in breast cancer cells. Studies on signaling mechanisms with 
MJ showed activation of TNFRl, caspase-8, p38, ERKl/2, and caspase-3 as well as 
mitochondrial membrane potential decrease in MDA-MB-435 cells. In MCF-7 cell 
signaling studies showed TNFRl expression, caspase-2 activation and decrease in
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mitochondrial membrane potential. This study indicates that MJ activates different 
signaling mechanisms depending on cell line. This is the first report to demonstrate that 
MJ decreases membrane fluidity and activated the death receptor TNFRl.
Recent reports with MJ showed growth inhibition of lung and leukemia cells [9]. 
Along similar lines, this study demonstrated that jasmonates inhibited the growth of 
breast cancer cells. It was reported that MJ induced apoptosis in human lung cancer cell 
line, A549 and this study determined that CJ and MJ induced apoptosis in MDA-MB-435 
and MCF-7 cell line. Cell cycle analysis revealed that CJ and MJ induced a block at 
GO/Gl in MDA-MB-435 and MCF-7 cells at all concentrations that were studied except 
in MCF-7 cells at 0.5 mM MJ or CJ an S-phase block was observed. This result indicates 
that the observed cell death was due to cell cycle arrest and apoptosis.
Earlier studies reported that the hydrophobic molecule DCA changes membrane 
fluidity. DCA decreases membrane fluidity by rearranging cholesterol in the membrane 
which makes the membrane tighter [35]. It has been reported that DCA induced 
apoptosis involves activation of caspases-2, caspase-3, caspase-7 and caspasea-8 in colon 
cancer cells (HT-29) [36-38]. In HCT-116 colon cancer cells DCA activated p38 and 
ERKl/2. Using pharmacological inhibitors to ERKl/2 determined that elevated ERKl/2 
activity suppressed DCA induced apoptosis. Taken together it suggests that DCA can 
activate different apoptotic proteins based on cell line [36-38]. No mechanism was 
proposed, however, activation of these molecules likely results due to the activation of 
receptor molecule (i e TNFRl) due to changes in membrane fluidity in the presence of 
DCA. Since MJ is a hydrophobic molecule like DCA it might work in a similar manner 
i.e. decreases membrane fluidity which assembles receptors and leads to
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autophosphorylation and activation of death receptors. This study determined that MJ 
decreased membrane fluidity results in apoptotic signaling in cancer cells. The results 
presented here (TNFRl, caspase-2, caspase-8, capase-3 and MAPK) and by others 
indicated that jasmonates induced apoptosis involves activation of multiple signaling 
pathways [9, 11, 2].
In conclusion, plant compounds have decreased membrane fluidity which further 
activated TNFRl. This study is important because apoptotic pathway can be manipulated 
for therapeutic purposes. MJ has shown to act on three different types of cancer cells 
hence it could be used for wide variety of cancer treatments. To reduce the toxicity of 
conventional chemotherapy to patients’ and improve the efficacy future combination 
studies (i.e MJ and cisplatin) at low dosage need to be carried out.
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7.9 Figure legend
Figure 1: Cytotoxicity of CJ or MJ on human breast cancer cells (MDA-MB-435 and 
MCF-7) as well as on human normal cells (CDC-1070-SK and MCF-lOA) in culture. 
Panel A: MDA-MB-435 and MCF-7 cells were exposed to varying concentrations of CJ 
for 24 hr. Panel B: MDA-MB-435 and MCF-7 cells were exposed to MJ for 24 hr. Panel 
C: CDC-1070-SK and MCF-lOA were exposed to different concentrations of MJ for 24 
hr. The effects on cell viability were determined by mitochondrial dehydrogenase assay 
using alamarBlue dye as described in methods section. Cell viability was calculated as a 
percentage of untreated cells (100%). Values were Mean±SD (n=6); results are 
representative of three independent experiments. At concentrations 1.5mM and higher 
there was a significant decrease in the viability of breast cancer cells compared to the 
control. One tailed t-test was carried out and at concentration 1 mM and above we 
observed statistically significant (p < 0.0001) decrease in viability. MJ was not cytotoxic
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to CDC-1070-SK and MCF-lOA cells (Panel C). Results are representative of three 
different experiments.
Figure 2: CJ and MJ inhibited the long-term proliferation of breast cancer cells. Panel 
A: MDA-MB-435 cells were exposed to varying concentrations of CJ or MJ for 24hr. 
Panel B: MCF-7 cells were exposed to varying concentrations CJ or MJ for 24 hr. Panel 
C: MDA-MB-435 cells were exposed to 3mM CJ or MJ for 0, 2, 4 and 8 hr. Panel D: 
MCF-7 cells were exposed to 3mM CJ or MJ for 0, 2, 4 and 8 hr. At termination the 
drugs were washed off and the effects on long term cell proliferation were determined. 
Colonies (>50 cells/colony) were counted and survival was calculated as percentage of 
control cells (100%). Values are Mean+SEM; results are representative o f duplicate 
analyses of two separate experiments. CJ and MJ significantly inhibited the long-term 
proliferation o f all two cell lines in dose and time dependent manner (p<0.001; one tailed 
t-test). Results are representative of two independent experiments.
Figure 3: Panel A: Representative histograms of MDA-MB-435 cells treated with 3mM 
CJ or MJ for 24 hr. Panel B: Representative histograms of MCF-7 cells treated with 3mM 
CJ or MJ. Panel C: MDA-MB-435 cells were treated with 0.5mM and 3mM CJ or MJ for 
24 hr. Both CJ and MJ induced a significant GO/Gl block in MDA-MB-435 cells and 
3mM MJ also induces S-block with increasing sub-diploid population. Panel D; CJ and 
MJ induced GO/Gl block in MCF-7 cells and 3mM CJ also induced S-block while 3mM 
MJ increased sub-diploid population. (Two-tailed t-test, p<0.05). Results are 
representative of two different experiments.
Figure 4: To confirm apoptosis induction in breast cancer cells were stained cells with 
Hoechst and fluorescence microscopy images were acquired. Panel A: Bright field image
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of MDA-MB-435 control cells (treated with 0.03% DMSO) Panel B: Hoechst image of 
MDA-MB-435 control cells. Panel C: Bright field image of MDA-MB-435 cells treated 
with 3mM CJ for 24hr. Morphological changes of apoptosis (cell shape changed from 
spherical to elongated and nuclear condensation was observed). Panel D: Hoechst image 
of MDA-MB-435 cells treated with 3mM CJ. Hoechst positive cells were observed. 
Hoechst positive cells with morphological changes were considered as apoptotic cells. 
Percent apoptosis was calculated as explained in the methods. Results are representative 
of two different experiments. Panel F: DNA gel picture of MDA-MB-435 and MCF-7 
cells treated with MJ for 24 hr. Lane 1 ; High DNA Mass™ Ladder shows 1000, 2000, 
3000, 4000, 6000, 10000 bp bands. Lane 2: MDA-MB-435 cells treated with 0.03% 
DMSO (Control). Lane 3: MDA-MB-435 cells treated with ImM MJ. Lane 4: MDA- 
MB-435 cells treated with 2mM MJ. Lane 5: MDA-MB-435 cells treated with 3mM MJ. 
Lane 6: MDA-MB-435 cells were treated with DCA for 4hr. Lane 7: MDA-MB-435 cells 
were treated with DCA for 8 hr. Lane 8: MCF-7 cells treated with 0.03% DMSO 
(Control). Lane 9: MCF-7 cells treated with ImM MJ. Lane 10: MCF-7 cells treated with 
2mM MJ. Lane 11 : MCF-7 cells treated with 3mM MJ. DNA smear was observed only in 
MDA-MB-435 cells treated with 3mM MJ and DCA treated cells were used as positive 
controls. Results are representative of three different experiments.
Figure 5: Increase in TNFRl and MAPK activity was measured as explained in methods. 
Panel A: TNFRl expression in MDA-MB-435 control. Panel B: TNFRl expression in 
MDA-MB-435 cells treated with ImM MJ for 24 hr. Panel C: TNFRl expression in 
MDA-MB-435 cells treated with 2mM MJ. Panel D: TNFRl expression in MDA-MB- 
435 cells treated with 3mM MJ. Increase in TNFRl expression is dose dependent and at
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3mM MJ a complete shift in fluorescence intensity was observed. Panel E; TNFRl cells 
treated with 0.3% DMSO. Panel F: TNFRl expression in MCF-7 cells treated with ImM 
MJ. Panel G: TNFRl expression in MCF-7 cells treated with 2mM MJ. Panel H: 
TNFRl expression in MCF-7 cells treated with 3mM MJ. In MCF-7 cells TNFRl 
expression is dose dependent and huge increase at 3mM MJ was observed. Panel I: In 
MDA-MB-435 cells increase in p38 phosphorylation was significant at 2hr (p<0.04) and 
starts decreasing from 4 hr till 8 hr. Panel J: In MDA-MB-435 cells significant increase 
in ERKl/2 phosphorylation was observed at Ihr (p<0.04). Results are representation of 
two independent experiments.
Figure 6: Panel A: Western blot of caspase-8 in MDA-MB-435 cells treated with 3mM 
MJ for 2 hr, 4 hr and 8 hr. Procaspase-8 was processed and cleaved to active caspase-8 at 
all the time points studied. Caspase-8 activity was increased with 3mM MJ treatment in 
MDA-MB-435 cells compared to the control. P-actin was a loading control. Panel B, C 
and D; Histograms of caspase-2 in MCF-7 cells. Panel B; MCF-7 cells treated with 0.3% 
DMSO Panel C: MCF-7 cells were treated with 3mM MJ for 4hr. A shift in fluorescence 
intensity was observed compared to control. Panel D: MCF-7 cells were treated 
simultaneously with 3mM MJ for 4 hr and caspase-2 inhibitor. Shift in fluorescence 
intensity was decreased compared to 3mM MJ treatment. Panel E: Western blot of 
procaspase-3. Decreased levels of procaspase-3 were observed in MDA-MB-435 cells 
treated with 3mM MJ. Panel F: Caspase-3 activity measurement by flow cytometry 
showed activation of caspase-3 in MDA-MB-435 cells but not in MCF-7 cells. Fold 
increase was calculated with respect to the control (1). Results are representative of two 
different experiments. Panel G: Mitochondrial membrane potential was determined in
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breast cancer cells as explained in methods. In both MDA-MB-435 and MCF-7 cells 
IC50 MJ and 3mM MJ decreased the membrane potential as observed by an increase in 
green fluorescence compared to the control.
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Table 1 : CJ and MJ induced apoptosis in breast cancer cells.
% apoptosis
Cell lines 0 3.0mM CJ 3.0mM MJ
MDA-MB-435 2.2±0.87 6.6+0.94 35.0+8.72
MCF-7 2.0±2.0 43.5+3.53 37.2±5.64
MDA-MB-435 and MCF-7 cells were exposed to 3mM CJ or MJ for 24 hr, stained with 
Hoechst and % apoptosis was calculated as explained in methods. Both CJ and MJ 
induced significant amount of apoptosis (p<0.01)
153
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 2: MJ decreases membrane fluidity in Breast cancer cells.
Treatment (4hr) MB-435 MCF-7
Control 0.29 ±0.05 0.32±0.005
Cholesterol 0.50 ±0.05 0.41±0.01
DCA 0.44 ±0.04 0.4±0.0
3mM MJ 0.40 ±0.05 0.41±0.01
MDA-MB-435 cells were treated with 3mM MJ for 4hr and polarization was measured 
and P value was calculated as explained in methods. There is significant decrease in 
membrane fluidity. (p<0.05, one tailed t-test)
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CHAPTER 8
PERILLYL ALCOHOL AND METHYL JASMONATE SENSITIZE BREAST 
CANCER CELLS TO CISPLATIN VIA TNFRl
8.1 Abstract
Introduction-The aim of the study was to evaluate the activity of a combination of perillyl 
alcohol (POH), methyl jasmonate (MJ) with cisplatin to define the most effective 
schedule, and to investigate the mechanism of action in human breast cancer cells. 
Methods-The study was performed on MDA-MB-435 cells. The cytotoxic activity was 
evaluated by mitochondrial dehydrogenase assay. Cell cycle analysis and an apoptotic 
assay were performed by flow cytometry. TNFRl activity and mitochondrial membrane 
potential were measured by flow cytometry.
Results- The POH, MJ treatment enhanced the cytotoxicity for subsequent exposure to 
cisplatin. Combination treatment of POH and MJ blocked cells at the GO/Gl phase of the 
cell cycle and the addition of cisplatin forced the cells to progress through the cell cycle 
or killed them. POH and MJ treatment activated TNFRl and it was further activated by 
the addition of cisplatin. Mticohondrial membrane potential was decreased with POH 
and MJ treatment which was further enhanced by cisplatin treatment.
Conclusion-This study revealed that POH, MJ and cisplatin together were more effective 
than single drug or two drugs in combination. It was also demonstrated that combination 
treatment activated TNFRl and decreased mitochondrial membrane potential.
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8.2 Introduction
Breast cancer, patients have several treatment options including surgery, 
chemotherapy, radiation therapy and a combination of these therapies. Due to 
disadvantages with single agent chemotherapy drug combinations at tolerable doses are 
administered to increase efficacy [1]. New strategies for breast cancer treatment such as 
the use of plant compounds in combination with chemotherapeutic drugs will improve the 
efficacy of current therapeutic regimens.
Perillyl alcohol (POH) and Methyl jasmonate (MJ) are plant compounds that can 
be used for combination therapy. POH is a naturally occurring monoterpne that inhibited 
growth of cancer cells and induced apoptosis [2-5]. A recent study reported that POH 
sensitized human myeloid U937 cells to pentoxifylline. Combination treatment of POH 
with pentoxyfylline increased Bclz and Bax expression as well as induced apoptosis [6]. 
POH has been reported to sensitize prostate and malignant glioma cells to 
cisplatin/radiation via Fas mediated death receptor pathway [7, 8]. Malignant glioma 
cells preincubation with POH demonstrated a dose dependent sensitivity to cisplatin and 
doxorubicin [8]. MJ is a plant stress hormone that inhibited growth of lung, breast and 
leukemia cells [9-11]. Combination studies of MJ with cisplatin, adriamycin, taxol, 
l,3bis {2-chloroethyl}-1 -nitusourea (BCNU) showed super-additive effects with BCNU 
and cisplatin in human pancreas carcinoma MIA PaCa-2 cells [11]. MJ in combination 
with taxol showed cooperative effects in MCF-7 cells but not in combination with 
cisplatin [11]. MJ enhances ATP depletion in the presence of glycolysis inhibitor, 2DG 
in CT26 (murine colon carcinoma) and D122 (murine lung carcinoma) cells [11]. These
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observations with combinations of plant compounds and chemotherapeutic drugs will 
provide new avenues for breast cancer treatment.
Cisplatin has antitumorigenic activities against wide variety of cancers but its 
nephrotoxicity limits the amount given to patients. Several groups have shown that 
cisplatin caused nephrotoxicity is a result of TNF-a release [12-14]. TN F-ais 
a proinflamatory cytokine, involved in diseases such as arthritis and multiple sclerosis. 
Its binds to two receptors, tumor necrosis factor receptor 1 (TNFRl) and tumor necrosis 
factor 2 (TNFR2) [15-19]. In B6 PTC (proximal tubular cells) cells (from C57BL/6 (B6) 
mice) cisplatin treatment increases TNF-a production and Fas expression [I2].TNF-a 
release in cell culture medium and Fas activation led to cell death in mice proximal 
tubular cells [12]. Hence, agents that sensitize cells to low dose of cisplatin will result in 
fewer side effects for the patient.
This study demonstrated that POH inhibited the growth of human breast cancer 
cells (MDA-MB-231, MDA-MB-435 and MCF-7) and induced apoptosis. The novel 
finding in the study is that POH (IC20), MJ (IC20) and of cisplatin (IpM) in combination 
showed synergistic effects in growth inhibition in MDA-MB-435 cells. The IC50 for 
cisplatin is 600 pM and in combination with POH and MJ it decreases to 1 pM which is a 
600 fold in increase in sensitivity to cisplatin. It was observed that combination 
treatment activated TNFRl and decreased mitochondrial membrane potential in MDA- 
MB-435 cells.
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8.3 Materials and methods 
Chemicals and reagents
Cell culture media (MEM), fetal bovine serum (PBS) and penicillin (1000 
units/ml) and streptomycin (1000 pg/ml) (P/S) were purchased from GIBCO (Grand 
Island, NY). Cis-jasmone (CJ), methyl jasmonate (MJ), cisplatin, propidium iodide (PI) 
and ribonuclease were obtained from Sigma Chemical Company (St. Louis, MO). 
Phosphate buffered saline (PBS, lacking Ca^^ and Mg^^) was purchased from Invitrogen 
Corporation (Grand Island, NY). All other reagents and chemicals were o f the purest 
grade and were obtained from reputable vendors.
Cell culture
Breast cancer cell lines (MDA-MB-231, MDA-MB-435, and MCF7) were 
obtained from ATCC (Manassas, VA). All cultures were maintained in MEM 
supplemented with 10% FBS, 1% of pencillin and streptomycin (lOOOunits/ml) and 
HEPES buffer. All the cultures were maintained at 37°C in humidified 5% CO2 
atmosphere. During exposure to the compounds medium was replaced with treatment 
medium containing various agents while control cells received medium with DMSO 
(0.1%-0.3%).
Cvtotoxicitv assav
Cells (5000) were plated in a 96-well plate and incubated overnight to adhere to 
the plate. Cells were exposed to varying concentrations of cisplatin and POH for 24hr. 
For combination treatments cells were exposed to either two or three compounds for 24 
hr. The concentration of POH or MJ was always at a dose that resulted in 20% decrease 
in cell viability (IC20) by the individual compound. Two agent combinations included:
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cisplatin and POH, cisplatin and MJ as well as POH and MJ, while the three agent 
combination included POH, MJ and cisplatin. At termination the medium was replaced 
with lOOpl of fresh medium, lOpl of alamarBlue was added and incubated for 4 hr. After 
4 hr fluorescence was measured at 530 nm excitation and 590 nm emission wavelengths 
with Genios fluorescence plate reader (PHENIX Research Products, Hayward, CA). Cell 
viability was calculated as percentage of control (100%).
Colonv formation assav 
The long-term (delayed) cytotoxic effects of agents on the breast cancer cells 
were determined using the colony formation assay (CFA). The cells were exposed to 0.5, 
1.0 and 2.0 mM concentrations of agents for 24 hr. The treatment medium was poured off 
and the cells were washed with IX PBS, harvested with trypsin EDTA, counted and 
replated into 60mm dishes. Cells were incubated in humidified CO2 atmosphere at 37°C 
for 11 days. The medium was decanted and cells were stained with crystal violet 
(0.5g/100ml in 95% ethanol). Colonies (>50 cells/colony) were counted and the 
percentage survival was calculated relative to the control (100%) group.
Cell cvcle analvsis bv propidium iodide 
Cells (0.5x10^) were plated in 100mm tissue culture plates, incubated overnight to 
adhere to the plate. Cells were exposed to 2mM POH for 24hr and washed with IX PBS. 
Fresh complete medium was added and incubated for 24hr. For combination treatments 
cells were exposed to either two or three compounds for 24 hr. The concentration of 
POH or MJ was always at a dose that resulted in 20% decrease in cell viability (IC20) by 
the individual compound. Two agent combinations included: cisplatin and POH, 
cisplatin and MJ as well as POH and MJ, while the three agent combination included
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POH, MJ and cisplatin. Cells were harvested with trypsin EDTA, washed with PBS, 
counted, fixed with lOOpl of PBS and 900pl of absolute ethanol and stored at 4°C prior to 
DNA content analyses. Samples were stained with DNA staining solution containing 
150pg/ml of PI, 0.1% Triton x-100 and 1 mg/ml of RNase-A (DNase free) (1:1:1 by 
volume) and incubated in the dark for an hour. Acquisition of the data was carried out 
with a FACSCalibur flow cytometer (Becton Dickinson, Sanjose, CA) and analyzed with 
ModfitLT 3.0 software (Verity Software House, Topsham, ME).
Detection of apoptosis bv Hoechst 
Cells (1x10" )̂ were plated in 4-well slides and incubated for 24hr before treatment. 
Cells were exposed to 2mM POH for 24hr, at termination medium was aspirated off and 
stained with Hoechst (2pg/ml Hoechst) for 15min. Morphological changes indicative of 
apoptosis were observed and the images were acquired with fluorescence microscopy 
(Nikon Instruments Inc. Melville, NY). The number of cells in the bright field and 
Hoechst stained cells were counted and percentage of apoptotic cells was calculated as:
% apoptosis = (Number of Hoechst positive cells/Number of cells in bright field) x 100.
TNFRl expression detection 
TNFRl expression was measured by flow cytometry [20]. MDA-MB-435 and 
MCF-7 cells were plated and after two days cells were exposed to 0, ImM, 2mM, 3mM 
MJ for 24 hr. Following exposure cells were harvested by scraping in PBS-EDTA 
(ImM), counted and 1x10^ cells were incubated in 50% FBS at 4°C for 15 min. Cells 
were washed with PBS-FBS (PBS with 1% FBS added) and incubated with 25pg/ml anti­
human TNFRl antibodies (R&D Systems, Emeryville, CA) at 4°C for 60 min. 
Subsequently cells were washed three times in PBS-FBS and incubated with FITC-
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conjugated goat anti-rat IgG (1:40 dilution) at 4°C for 2 hr. Cells were washed in PBS- 
FBS three times and analyzed with FACS Calibur flow cytometer. Fluorescence data 
was collected and background fluorescence was determined using unstained cells.
Mitochondrial membrane potential studies 
Mitochondrial membrane potential was measured as described in manufacturer’s 
protocol (Cell technology, Mountain View, CA). MDA-MB-435 cells were plated and 
incubated overnight. Cells were exposed to different combinations of cisplatin, POH and 
MJ (IC20 POH and MJ or IC20 POH (concentration that kills 20% of cells) and cisplatin 
(IpM) or IC20 MJ and cisplatin as well as combination of IC20POH, IC20MJ and 
cisplatin) for 24 hr. At termination cells were harvested, counted, washed with PBS, 0.5 
X 10  ̂cells were stained with JC-1 reagent and incubated for 15 min at 37° C. Cells were 
washed twice with assay buffer (provided by manufacturer) and membrane potential was 
measured by flow cytometry. Intact mitochondria have a red color fluorescence which 
changes to green with a decrease in mitochondrial membrane potential.
8.4 Statistical analyses 
The results were presented as Mean ± SEM of replicate analyses accompanied by the 
number of independent experiments. Statistical analyses were performed using one or 
two tailed t-test (Graphpad Software Inc., San Diego CA and Microsoft Excel). 
Differences at p<0.05 or better were considered statistically significant.
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8.5 Results
POH inhibited the proliferation of breast cancer cells 
The proliferation inhibition of breast cancer cells was determined by cytotoxicity 
assay using almarBlue dye. POH inhibited breast cancer cell growth in vitro. MDA-MB- 
231 and MDA-MB-435 were the most sensitive to POH (Figure lA). The IC20 value 
was calculated by visual inspection. The concentration of POH at which 20% of MDA- 
MB-231 cells growth (IC20) was inhibited after 24 hr treatment was 1.0 mM, 0.6 mM for 
MDA-MB-435 and 0.8 mM for MCF-7 cells (Figure lA). Long-term proliferation 
inhibition of breast cancer cells by POH was evaluated by clonogenic survival assay 
(Figure IB). The concentration of POH at which 50% of MDA-MB-231 cells 
proliferation was inhibited after 24 hr treatment was 1.5 mM, 1.5 mM for MDA-MB-435 
and 0.8 for MCF-7 cells (Figure IB). At ImM POH MCF-7 cells showed 25% survival 
whereas MDA-MB-231 and MDA-MB-435 cells showed 95% survival. POH at 2mM 
resulted in 2% survival in all three cell lines (Figure IB). Cell cycle analyses showed a 
GO/Gl block in all three breast lines studied (Figure 2).
Combination studies demonstrated that POH, MJ and cisplatin showed cytotoxic 
effects in growth inhibition compared to POH and MJ, POH and cisplatin as well as MJ 
and cisplatin treatments (Figure 3A). POH and MJ together showed only 25% growth 
inhibition in MDA-MB-435 cells (appendix).
Cell cvcle arrest and apoptosis in breast cancer cells 
To investigate the cell cycle arrest, DNA content analyses was carried out by 
propidium iodide staining using flow cytometry. POH produced a block in the cell cycle 
and also induced apoptosis in breast cancer cell lines (Figure 2). POH induced GO/Gl
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arrest with increasing the sub diploid population (apoptotic population) in MDA-MB-231 
(Figure 2A and 2B), MDA-MB-435 (Figure 2C and 2D) and MCF-7 (Figure 2E and 2F) 
cells. Studies with combination treatments showed a GO/Gl block at all combinations 
that were studied with increasing sub-diploid population (Figure 3B)
POH induced apoptosis in breast cancer cells (Table 1). To further confirm 
apoptosis induction cells were stained with Hoechst, images were acquired with 
fluorescence microscopy and percent of apoptotic cells was calculated as explained in 
methods. POH showed significant increase in apoptosis with breast cancer cell lines 
(Table 1). POH induced 33.7% apoptosis in MDA-MB-231, 12.1% in MDA-MB-435 
and 12.6% in MCF-7 respectively (Table 1)
TNFRl activation
TNFRl activation was measured by flow cytometry. TNFRl activation was 
observed in combination treatments in MDA-MB-435 cells. A shift in fluorescence 
intensity of histograms was observed in POH and MJ, POH and cisplatin, MJ and 
cisplatin as well as in POH, MJ and cisplatin treatments. The largest increase in 
fluorescence intensity was observed with the combination treatment of POH, MJ and 
cisplatin. The results indicated that three drugs (POH, MJ and cisplatin) in combination 
activated larger amounts of TNFRl in MDA-MB-435 cells compared to drugs in 
combination of two (POH and MJ, POH and cisplatin as well as MJ and cisplatin). 
Mitochondrial membrane potential detection:
To determine the involvement of mitochondria in combination treatment of POH, 
MJ and cisplatin membrane potential of mitochondria was measured by flow cytometry. 
It was demonstrated that mitochondrial membrane potential was decreased in
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combination treatments compared to the control. The highest decrease in membrane 
potential was observed with a combination treatment of POH, MJ and cisplatin.
8.6 Discussion and conclusion
Combination therapies will provide an alternate treatment option to reduce the 
toxicity and increase the efficacy of single agent therapy. This is the first report to 
demonstrate that POH, MJ and cisplatin in combination resulted in growth inhibition. 
DNA content analysis with combination treatments showed a GO/Gl block with 
increasing hypo-diploid population (apoptosis). Studies on the mitochondrial membrane 
potential and TNFRl indicated decreased mitochondrial membrane potential and 
activation of TNFRl in POH and MJ, POH and cisplatin, MJ and cisplatin as well as 
POH, MJ and cisplatin treatments.
Previous studies reported that POH inhibited the growth of lung, prostate and 
colon cancer cells [2-5]. It has been reported that POH induced GO/Gl block in lung and 
colon cancer cells as well as G2/M block in prostate cancer cells with increasing the 
apoptotic population [9-11]. Along similar lines this study demonstrated that POH 
inhibited growth, induced a GO/Gl block and caused apoptosis in breast cancer cells. 
Previous studies on MJ showed cytotoxic effects at 1-5 mM range in lung and leukemia 
cells [9-11]. Cisplatin at 6.6pM inhibited 48% cell growth and combination with 50- 
lOOpM silibinin resulted in 63-80% growth inhibition of prostate cancer cells [21]. In 
this study it was demonstrated that cisplatin at IpM concentration showed 2 % growth 
inhibition whereas with IC20POH and IC20 MJ showed 68 % growth inhibition. The 
IC50 (50% growth inhibition) value of cisplatin in MDA-MB-435 cells was 0.6 mM and
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cisplatin in combination with IC20POH and IC20MJ decreased the IC50 to 1 pM which 
is a 600 fold shift in IC50. This indicated that treatment of breast cancer cells with plant 
compounds increased cisplatin cellular toxicity.
Earlier reports on combination studies with POH and cisplatin demonstrated that 
POH sensitized prostate cancer cells to cisplatin and activated the Fas mediated death 
pathway and decrease mitochondrial membrane potential [7, 22]. Cisplatin was reported 
to release TNF-a into the cell culture medium and activated TNFRl in proximal tubular 
cells [13, 14]. In our previous studies it was determined that MJ activated TNFRl in 
prostate and breast cancer cells and decreased membrane potential in breast cancer cells 
(manuscripts submitted). Taken together all these observations and the combination 
studies demonstrated that POH, MJ and cisplatin treatment activated TNFRl and 
decreased mitochondrial membrane potential. The proposed mechanism for growth 
inhibition with combination treatment includes TNF-a release by cisplatin exposure and 
activation of TNFRl as well as mitochondrial membrane potential decrease by MJ and 
POH.
Cancer patients have disadvantages with single agent therapy such as side effects 
and severe toxicity. Combination studies involving two or more agents to reduce toxicity 
and improve efficacy of chemotherapy will provide new avenues for cancer treatment. 
This study indicated that combination treatments activated TNFRl and further scheduling 
and mechanistic studies at different doses need to be carried out to improve the efficacy 
of cisplatin.
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8.9 Figure legend
Figure 1: Cytotoxicity of POH on human breast cancer cells MDA-MB-231, MDA-MB- 
435 and MCF-7. Panel A: MDA-MB-231, MDA-MB-435 and MCF-7 cells were exposed 
to varying concentrations of POH for 24 hr and viability was measured by mitochondrial 
dehydrogenase assay as explained in the methods section. Cell viability was calculated 
as a percentage of untreated cells (100%). Values were Mean±SEM (n=6); results are 
representative of three independent experiments. A one tailed t-test was carried out and 
at concentrations of 1 mM and above a statistically significant (p < 0.0001) decrease in 
viability was observed. Panel B: POH inhibited the long-term proliferation of breast 
cancer cells. Cells were exposed to varying concentrations of POH and percent survival 
was determined as explained in the methods section. MDA-MB-231 and MDA-MB-435 
cells showed significant decrease in survival at 2mM POH (p<0.001) whereas in MCF-7 
cells both 1 and 2 mM POH caused significant decrease in survival (one tailed t-test, 
p<0.001). Values were Mean±SEM (n=3); results are representative of two independent 
experiments.
Figure 2: Representative histograms of breast cancer cell lines exposed to 2mM POH. 
Panel A: MDA-MB231 cells were exposed to 0.2% DMSO for 24 hr to compensate for 
the DMSO present in cisplatin treated cells. Panel B: MDA-MB-231 cells were exposed 
to 2 mM POH for 24 hr. Panel C: MDA-MB-435 cells were exposed to 0.2% DMSO for 
0, 24 hr. Panel D: MDA-MB-435 cells were exposed to 2 mM POH for 24 hr. Panel E: 
MCF-7 cells were exposed to 0.2% DMSO for 24 hr Panel F: MCF-7 cells were exposed 
to 2 mM POH for 24 hr. POH induced significant GO/Gl (two tailed t-test, p<0.01) arrest
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in all three cell lines studied Values are MeantSEM; results are representative of 
duplicate analyses of two separate experiments
Figure 3: Panel A: Cells were exposed to cisplatin alone, cisplatin with IC20 POH, 
cisplatin with IC20 MJ and cisplatin with IC20POH and IC20MJ. Combination of POH, 
MJ and cisplatin enhanced growth inhibition compared to the drugs in combination of 
two. Panel B: Cells were exposed to POH, MJ and cisplatin as explained in methods 
section. A significant GO/Gl block was observed at all combinations that were studied 
with increasing the sub-diploid populations. (Two tailed t-test, p<0.05)
Figure 4: In MDA-MB-435 cells activation of TNFRl was measured by flow cytometry. 
Panel A; Cells were exposed to 0.2% DMSO to compensate for the DMSO present in 
cisplatin treated cells. Panel B: Cells were exposed to 1C20 POH for 24 hr. Panel C: 
Cells were exposed to 1C20 MJ for 24 hr. Panel D: Cells were exposed to cisplatin 
(IpM) for 24 hr. Panel E: Cells were exposed to 1C20 POH and 1C20 MJ for 24 hr. 
Panel F: Cells were exposed to 1C20 POH and cisplatin (IpM). Panel G: Cells were 
exposed to IC20 MJ and cisplatin (IpM). Panel H. Cells were exposed to IC20 POH, 
IC20 MJ and cisplatin (IpM) for 24 hr. TNFRl activation was observed only in 
combination treatments (POH and MJ, POH and cisplatin, MJ and cisplatin as well as in 
POH, MJ and cisplatin treated cells) which was determined by a shift in fluorescence 
intensity of histograms. Results are representative of two independent experiments. 
Figure 5: Mitochondrial membrane potential was determined in breast cancer cells using 
a fluorescent dye. Panel A: MDA-MB-435 cells were exposed to DMSO. Panel B: Cells 
were exposed to IC20 POH for 24 hr. Panel C: Cells were exposed to IC20 MJ for 24 hr. 
Panel D: Cells were exposed to IC20POH and IC20 MJ for 24 hr. Panel E: Cells were
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exposed to IpM cisplatin for 24 hr. Panel F: Cells were exposed to IC20 POH and IpM  
cisplatin for 24 hr. Panel G: Cells were exposed to IC20 MJ and 1 pM cisplatin. Panel H; 
Cells were exposed to IC20POH, IC20 MJ and IpM cisplatin. In MDA-MB-435 
treatments an increase in green fluorescence indicated decreased membrane potential.
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Table 1: POH induced apoptosis in breast cancer cells
Cell lines Control 2.0mM POH
MDA-MB-231 9.84±0.16 33.7±5.71
MDA-MB-435 2.2±0.87 12.1+2.14
MCF-7 2.0+2.0 12.6+2.33
POH showed significant increase in apoptotic population compared to the control in all 
three breast cancer cells (one tailed t-test; p<0.01).
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CHAPTER 9
SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS
9.1 Novel findings
1. Jasmonates inhibited the growth of prostate and breast cancer cells.
2. Jasmonates induced cell cycle arrest and apoptosis in prostate and breast cancer 
cells.
3. Jasmonates decreased the membrane fluidity of breast cancer cells and activated 
the death receptor pathway.
4. MJ activated TNFRl in lung, prostate and breast cancer cells.
5. MJ activated caspase-8, caspase-2 (western needs to be done to confirm), MAPK, 
caspase-3 and also decreased the mitochondrial membrane potential of breast 
cancer cells
6. Combination studies enhanced growth inhibition of breast cancer cells with POH, 
MJ and cisplatin. Results demonstrated activation of TNFRl with combination 
treatment of POH, MJ and cisplatin at low doses.
7. MJ sensitized breast cancer cells to radiation.
8. Microarray analysis on breast cancer cells with MJ showed changes in gene 
expression prolife. Further studies need to be carried out to confirm the specific 
changes (i.e.: CDC25, ASF-1) in gene expression.
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9.2 Jasmonates
Earlier, Flescher et al., demonstrated that jasmonates possess cytotoxic and 
antitumorigenic properties and also reported that jasmonates inhibited the growth of 
leukemia cells [7]. Along similar lines, this study revealed that jasmonates inhibit the 
growth of lung, prostate and breast cancer cells which are the three most commom forms 
of cancer (Chapters 3-8). Mitochondrial dehydrogenase assay demonstrated that the 
breast cancer cell line, MDA-MB-435 is more sensitive to CJ or MJ than other cell lines 
that were tested. To understand the rationale behind the growth inhibition, cell cycle 
analysis was performed and the process of cell death (apoptosis or necrosis) was 
investigated. It was found that jasmonates induce cell cycle arrest and apoptosis in all 
three different types of cancer cell lines that were studied, which is in agreement with the 
literature [7, 8]. DNA content analyses showed that jasmonates induced a G2/M block in 
lung cancer cells, a Gq/Gi arrest in prostate cancer cells and Gq/Gi and S-phase arrest in 
breast cancer cells. This is the first report to demonstrate that CJ and MJ increase p21 
levels in cancer cells, which confirms the cell cycle arrest caused by these compounds. 
Previous studies have demonstrated that jasmonates induce apoptosis by selectively 
causing damage to mitochondria [8]. On the other hand, the current study shows that MJ 
affects the membrane fluidity of cancer cells and sends death signals via TNFRl. It has 
been determined that jasmonates decrease membrane fluidity and causes receptors to 
converge and become activated. It has been reported that a hydrophobic molecule, 
deoxycholic acid (DCA) decreases membrane fluidity and activates downstream proteins 
such as MAPK [65-67]. Since jasmonates are hydrophobic molecules they probably 
work in a manner similar to DCA. Another novel finding in the study is tiiat, MJ
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activated TNFRl in all three different types of cancer cells. To further confirm TNFRl 
expression, caspase-8 and caspase-2 (initiator caspases) activation was measured and 
found to be activated. A finding that is consistent with the activation of TNFRl. Further 
studies on intrinsic apoptotic mechanisms showed that MJ decreased mitochondrial 
membrane potential and activated caspase-3 resulting in cell death which is in agreement 
with the literature [8,42].
9.3 Monoterpenes
Earlier reports showed that growth of lung, prostate and colon cancer cells was inhibited 
by PA and POH [29-32]. In this study, PA and POH inhibited growth, induced cell cycle 
arrest and apoptosis in lung and breast cancer cells. A novel finding of this study is that 
PA increased p21, Bela levels, activated bax and caspase-3 resulting in apoptosis.
9.4 Combination treatments 
Several groups have demonstrated that combination therapy could be a new approach for 
cancer treatment. Combination studies with PA and POH showed that lung cancer cells 
were sensitized to cisplatin and radiation following pretreatment with these 
monoterpenes. To the best of our knowledge, this is the first report to demonstrate that 
MJ sensitized cells to radiation. An interesting observation is that MJ (IC50MJ 2hr) at 
sensitized breast cancer cells to low dose radiation (2 Gy) (Appendix). This could have 
clinical benefit because MJ being a plant compound would be less toxic to cells than 
other chemotherapeutic drugs (i.e. cisplatin) and low dose radiation does not have any 
severe side effects. Combination of POH and MJ with cisplatin at very low dose showed
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synergistic effects in growth inhibition while molecular mechanism studies measured a 
decrease in the mitochondrial membrane potential and increased TNFRl activation in 
breast cancer cells. Hence combination studies with low dosage of drugs could result in 
significant clinical improvement for patients on single agent therapies
9.5 Significance of novel findings 
The novel findings of this study are significant for several reasons. The results of this 
study are consistent with the literature reports about plant compounds effects on leukemia 
cells [7, 8]. The results have been expanded to lung, prostate and breast cancer cells 
which are three most common forms of solid tumors. Compounds studies (POH and MJ 
with cisplatin as well as MJ and radiation) indicate that these plant compounds will 
improve the efficacy of conventional treatments. Activation of multiple signaling 
pathways by MJ and broad activity on different types of cancer cells (lung, prostate and 
breast) suggests that MJ will be effective on wide variety of cancers. Results presented in 
this preclinical study provide useful information for future animal and clinical studies.
This study supports the literature about plant compounds effects on cancer cells and 
also expands research on lung, prostate and breast cancer cells. Plant compounds usually 
are less toxic to the cells which makes this research important. Plant compounds 
inducing cell cycle arrest will help control the growth of cancer cells and ultimately lead 
to cell death. Results presented in this study with cancer cell lines provide useful 
information for future animal and clinical studies. Combination studies (POH and MJ 
with cisplatin, MJ and radiation) will improve the efficacy of conventional treatments. 
Activation of multiple signaling pathways by MJ and broad activity on different types of
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cancer cells (lung, prostate and breast) suggests that MJ can be effective on wide variety 
of cancers.
9.6 Future Directions
• Does MJ cause the release of TNF-a like cisplatin and thereby result in an 
autocrine response and activation of TNFRl?
• Structure and function study of jasmonates: Will CJ (member of jasmonate family) 
affect the cancer cells in similar manner to MJ? Will others in jasmonate family (24 
different compounds) work through the same mechanism as MJ did in inducing 
apoptosis?
• MJ can be modified chemically which hopefully will increase cellular toxicity: Will 
phenyl group addition make MJ more hydrophobic and more effective on cancer cells? 
Will addition of more hydroxyl groups make MJ hydrophilic and decrease the potential 
cytotoxic effects of MJ?
• Will MJ activate any other death receptors FAS, DR1-DR6?
• Does combination treatment of POH, MJ and cisplatin involve any other signaling 
pathways like MAPK and FAS?
• What is the mechanism involved in MJ induced sensitivity to low dose radiation?
• Animal studies: Preventive studies will involve MJ by itself, MJ derivatives and MJ 
in combination with other drugs such as POH as well as cisplatin. This will provide 
information about the toxicity of MJ, derivatives of MJ and MJ in combination with other 
drugs.
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APPENDIX
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Figure 1: DC4, DB46, MDA-MB-435 and MCF-7 cells were exposed to CJ or MJ for 24 
hr and viability was measured as explained in methods. At concentrations 1.5 mM and 
higher CJ and MJ showed significant decrease in viability (p<0.001).
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Figure 2: MCF-7, T47-D, SK-BR-3 and ZR-751 cells were exposed to CJ and MJ for 24 
hr. Cell viability was measured as explained in methods. At concentration 1.5 mM and 
above both CJ and MJ inhibited the growth o f breast cancer cells (p<0.001).
189
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
A ■IR
120 1 IC50MJ+IR
100
80-
60 ■
40-
2 0 -
0 1 2 3 4 5 6
B
Gy
120 1
IR
IC50MJ+IR100
80-
40-
2 0 -
0 1 2 3 4 5 6
Gy
Figure 3: MDA-MB-435 (A) and MCF-7 (B) cells were exposed to IR alone and a 
combination of MJ (2hr) and IR (2Gy). Survival assay was carried out as explained in 
the methods. MJ sensitized breast cancer cells to radiation (p<0.01).
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Figure 4: A549 cells were exposed to 0.3% DMSO (A) and 3mM MJ (B) for 24 hr and 
TNFRl activation was determined by flow cytometry. In A549 cells TNFRl was 
activated which was observed by the shift in fluorescence intensity.
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Figure 5: Cells were exposed to IC20 POH, IC20MJ as well as IC20 POH and IC20 MJ 
for 24 hr and viability was measured as by alamarBlue assay. POH and MJ in 
combination decreased 30% viability in MDA-MB-435 cells.
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ABBREVIATIONS
CDK Cyclin dependent kinases
CJ Cis-jasmone
DMSO Dimethyl sulfoxide
EDTA Ethylene diammine tetraacetic acid
FACS Fluorescence activated cell sorting
FBS Fetal bovine serum
FITC Fluorescence isothiocyanate
IR Ionizing radiation
MAPK Mitogen activated protein kinases
MJ Methyl j asmonate
NSCLC Non small cell limg cancer cells
PA Perillic acid
PBS Phosphate buffer saline
POH Perillyl alcohol
SDS-PAGE Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
TNF-a Tumor necrosis factor alpha
TNFRl Tumor necrosis factor -1
TNFR2 Tumor necrosis factor -2
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